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                                                              ABSTRACT  
 
An unnaturally expressionless, vapid face with skin that appears to be drawn way too tight, is 
often the image that flashes to mind when we hear the word “Botox”. Yet when done correctly, 
this aesthetic procedure guarantees to soften wrinkles and brighten the skin, hence it is a 
popularity among celebrities looking to maintain a youthful appearance. 
From the ceaseless stream of smooth jawlines and chiselled cheekbones to celebrity plastic 
surgeons posting images of their work, the age of continuous self-documentation has impelled 
a unique set of beauty ideals and an intense increase in cosmetic procedures. Whilst most 
doctors suggest focusing on skin integrity by advising on appropriate beauty regimens, 
there are exceptions. ‘Botox’ is the exception. Botox (onabotulinumtoxinA), also called 
botulinum toxin type A, is made from the bacteria that causes botulism.  Botox treatments are 
becoming more extensive and recognised and to some it seems to be an acceptable way to elude 
the signs of aging.  Botox works by relaxing the contraction of muscles by blocking nerve 
impulses which results in muscle relaxation and softening of wrinkles. 
 According to the American Society of Plastic Surgeons, in 2015, more than 6.7 million Botox 
procedures were executed, making it the most popular minimally invasive cosmetic procedure. 
 
In South Africa Botox is recognised as a prescription-only drug which requires that it should 
be prescribed by a doctor and administered by a suitably trained and qualified clinician. It is 
therefore illegal for a person who does not have the requisite qualification, skills and 
knowledge to administer Botox is a   neurotoxin which can cause serious adverse effects if used 
incorrectly.  
 
Before 2007, controversy existed regarding the suitability of Botox in dentistry. Dentists were 
accused of abandoning their conventional roles of fixing gums and teeth and venturing into 
administering Botox.  There are circumstances when the use of Botox and similar treatments 
can be deemed to be related to the practice and scope of dentistry. Thus the aim of this thesis 
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW 
1.1. Introduction 
This chapter presents the problem and research questions on which this study focuses and 
reviews the relevant literature. 
Medical and dental technology is rapidly advancing, resulting in the development of new 
procedures to improve aesthetic and functional disorders with greater ease. Patients’ awareness 
of these expanding alternatives has resulted in increasing demand for this growing range of 
new treatments.  Treatments based on the administration of botulinum toxin (BT), commonly 
known as ‘Botox’, provide temporary, less invasive and relative risk free alternatives that have 
been demonstrated to be effective in the management of a wide range of dental disorders and 
aesthetic conditions, including temporomandibular disorders, bruxism, clenching, masseter 
hypertrophy, deep nasolabial folds, radial lip lines, high lip line and black triangles between 
teeth.1 Botox has thus expanded the range of treatment options which could potentially be 
offered by dentists; however, the regulatory environment governing the practice of dentistry 
does not address the use of Botox directly, leaving the question of whether, and to what extent, 
it can be used in dentistry in a grey area. 
 
1.2. Statement of the problem 
A wide range of positions exist on the question of whether or not it is ethical for dentists to 
conduct cosmetic procedures at all and, if so, to what extent and whether the practice is 
adequately regulated.2 In South Africa, dentists are limited to the scope of practice defined by 
the Health Professions Act3 which, in Section 33, stipulates that “a dentist can perform a 
cosmetic procedure on a patient to the oral and perioral area.”4 This is a very general guideline 
and it is unclear whether it includes the administration of Botox. 
                                                 
1 D Mostafa ‘A successful management of severe gummy smile using gingivectomy and botulinum toxin injection: 
A case report’ (2018) 42  International Journal of Surgery Case Reports, 169-174. 
2 Ibid. 
3 The Health Professions Act 56 of 1974. 
4 ‘Health Professions Council of South Africa: Policy and Guidelines’, available at 
https://www.hpcsa.co.za/PBMedicalDental/Guidelines , accessed on 12 May 2018.   
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While Botox is administered by dentists for lip augmentation as an adjunct to denture therapy 
or solely to enhance the lips,  it has been argued that dentists are better qualified than other 
professional health care providers to administer Botox safely and effectively to other areas of 
the face as well.5 While Botox treatment is not included in the undergraduate curriculum for 
dentistry, the specialised training which dentists receive for the head and neck area in their 
undergraduate training in anatomy, physiology and pharmacology6, in addition to the training 
and experience acquired during their postgraduate training, results in dentists developing a high 
level of expertise appropriate to the administration of both aesthetic and therapeutic Botox.7 
As members of the Dental Protection Society (DPS), dentists enjoy professional indemnity 
which covers malpractice and medico-legal risks. However, in its 2017 annual report the Health 
Professions Council of South Africa8 indicated that the number of complaints and legal cases 
relating to medical negligence and malpractice are rising annually. The Dental Protection 
Society reports that complaints and litigation against dentists relate to one of the following four 
issues: 
 failure to inform the patient adequately as to the expected aesthetic result or possible 
adverse effects, resulting in the patient’s consent being inadequately informed; 
 discontentment with the outcome of the  aesthetic procedure,  frequently associated 
with a disproportionate outcome and ‘lumping’ in the case of dermal fillers; 
 hypersensitive reactions resulting in anaphylaxis;  
 post-operative pain and skin discoloration.9 
While dentists may possess the necessary expertise to administer Botox, the rise in the number 
of reports by dental patients of medical negligence and malpractice highlights the importance 
of dentists exercising due diligence for the benefit of their patients as well as to uphold the 
reputation of their profession.  
 
                                                 
5 ‘Should-dentists-be-allowed-to-administer-botulinum-toxin’ available at  https://www.omicsonline.org/ -, 
accessed on 24 November 2018. 
6 ‘Academic Programmes’ – University of Pretoria, available at  
http://www.up.ac.za/en/odontology/article/22379/academic-programmes, accessed on 12 May 2018. 
7 Ibid. 
8 ‘HPCSA_annual_report 2017 2018 pdf,’ available at 
http://www.hpcsa.co.za/Uploads/editor/UserFiles/downloads/publications, accessed on 26 November 2018.  
9 ‘Academic Programmes’ – University of Pretoria, available at  




1.3. Purpose of the study  
Against this background, this study investigates the critical and legal issues surrounding dental 
Botox. In particular, the study explores whether the administration of Botox falls within the 
scope of practice of dentists in South Africa and, if so, whether this includes treatment to the 
face. It also explores the regulatory framework which governs the administration of Botox by 
dentists and examines whether legal or policy reform is needed in this area. 
This study aims to answer the research questions by examining the scope of practice of dentists 
with regard to the use of Botox. The study will: 
(i) examine the scope of other professions with regard to the administration of Botox; 
(ii) examine medical malpractice in the context of the administration of dental Botox; 
(iii) investigate possible medical negligence/liability with regard to dentists who administer 
Botox elsewhere on the face; and 
(iv) based on the findings, make recommendations to improve the administration of Botox to 
dental patients. 
 
1.4. Research questions 
This study investigates the following research questions: 
(i)  Does the administration of Botox fall within the scope of practice of dentists in South 
Africa?  
(ii) Does the administration of Botox to a patient’s face fall outside of the scope of practice   of 
a dental surgeon and thus constitute medical malpractice?  
(iii) Does a regulatory framework exist which governs the administration of Botox by  dentists? 
(iv) Is there a need for legal or policy reform with regard to the administration of Botox by 
dentists? 
 
1.5. Structure of the dissertation 
 The dissertation comprises four chapters which are structured as follows: 
10 
 
Chapter One: This chapter provides a background to the research topic, identifies the research 
problem and the significance of the study, reviews the literature relevant to the study and 
presents the aims and expected outcomes of the study. 
Chapter Two: This chapter investigates the legal issues surrounding Botox in South Africa.  
The issues of standards of dental care, medical malpractice and negligence are explored. 
Chapter Three: This chapter explores a study in which the United States of America (USA) 
and the United Kingdom (UK) identified and addressed legal issues arising from the use of 
dental Botox.  
Chapter Four: This chapter presents a summary of the findings of the study and provides 
recommendations informed by these findings.  
 
1.6.  Literature review  
This section presents academic views and findings in the literature addressing the critical 
legal issues surrounding the use of Botox in dentistry. 
 
1.6.1 Development of Botox  
 
1.6.1.1 Botulinum toxin 
Botulinum toxin is a neurotoxin produced by the Gram-positive bacterium Clostridium 
botulinum under anaerobic conditions.10 Botulinum is one of the most fatal toxins known and 
has found applications in bioterrorism as well.11  If foods containing this toxin are consumed, 
the toxin spreads to the peripheral cholinergic nerve endings, inhibiting the release of 
acetylcholine, a neurotransmitter which triggers muscle contraction and glandular secretion, 
resulting in the bilaterally symmetric descending neuroparalytic illness12 botulism, first 
described by Kerner.13  
 
1.6.1.2 Acceptance for therapeutic use 
                                                 
10 D Truong, D Dressler & M Hallett Manual of Botulinum Toxin Therapy 2 ed  (2009) 10. 
11 SS Arnon, R Schechter, TV Inglesby, et al. ‘Botulinum Toxin as a Biological Weapon: Medical and Public 
Health Management’ (2001); 285(8) Journal of the American Journal Association 1059–1070.  
12 Ibid. 
13 D Truong, D Dressler & M Hallett. Manual of Botulinum Toxin Therapy 2 ed (2009) 10.  
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Botulinum toxin (BT), or ‘Botox’, is the first toxin to be accepted for therapeutic uses.14 The 
therapeutic use of the toxin was pioneered by German physician Justinus Kerner.15 Kerner 
reported that “the toxin intercepted the signal transmission within the peripheral sympathetic 
nervous system, allowing the sensory transmission to remain unhindered.”16 Botulinum toxin’s 
potential to restrict acetylcholine release at the neuromuscular junction has been used 
extensively in medical conditions which manifest increased muscle movement.17  
The mechanism of action for Botox is fairly simple.18 On the administration of Botox into the 
muscles of the face the neurotransmitter that innervates the muscles are affected and blocked.19 
Patients may become partially or completely immune to repeated injections due to antibodies 
that neutralise the neurotoxin.20 The incidence of immune resistance differs for each patient 
depending on study modulation and treatment indicators; complexing proteins may increase 
the immune response by acting as adjuvants. The complexing proteins are vital in “neutralising 
and non-neutralising antibodies in the response to botulin toxin.”21 Despite the fact that it is a 
lethal toxin, compared to other treatment options Botox treatment is relatively safe.22 Botox 
treatments are the most frequently conducted minimally invasive aesthetic procedure in North 
America.23 
1.6.1.3 Composition 
Different compositions of botulin toxin (BT) have been produced. 24 The primary commercially 
available preparations of botulinum toxin are Botox (onabotulinumtoxin A; manufactured by 
Allergan, Inc. in Ireland); Dysport (abobotulinumtoxin A; manufactured by Ipsen Ltd in the 
UK); and Xeomin (incobotulinumtoxin A; botulinum toxin type A [150 kD], free from 
complexing proteins; ‘NT 201;” (Merz Pharmaceuticals GmbH, Germany).”25 The new 
botulinum toxin is used to assist with the reduction of immune resistance in people with long 
                                                 
14 A Azam, S Manchanda, S Thotapalli & SB Kotha ‘Botox Therapy in Dentistry: A Review’ (2015) 7(2) Journal 
of International Oral Health 103–105. 
15 Ibid.  
16 Ibid. 
17 Ibid.  
18 Ibid. 
19 Ibid.  
20 Ibid. 
21 Ibid.  
22 Ibid. 
23 Ibid. 
24 Ibid.  
25 Ibid.  
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term ailments.26 BTs can be differentiated into seven types, from A to G,27 however 
commercially available variants are purified exotoxin and only BT type A (BTA) and BT type 
B (BTB) are promoted by a range of brand names. BTA is promoted as ‘Botox in’ the USA; 
‘Dysport’ in the UK and Europe; ‘Xeominin’ in Germany; and ‘Prosigne’ in China.28 ‘Botox’ 
is a trade name for botulinum toxin, which is in the form of a purified protein.29 
In 2008, nearly 2.5 million cosmetic procedures were conducted using Botox, accounting for a 
quarter of all cosmetic procedures that year.30  Although Botox has been mostly associated with 
therapy for purposes of achieving cosmetic results, its benefits and uses go beyond such 
cosmetic applications31 and include facial dystonia, spasticity, salivary flow, non-dystonic 
disorder, sweating disorders, fistula treatment and temperomandibular discomfort.32  Since the 
first therapeutic use for strabismus, the spectrum of therapeutic applications of BTs has 
expanded to include its injection into extra ocular muscles as an alternative to strabismus 
surgery.33  It is argued that for almost thirteen years—until Botox Cosmetic was introduced in 
2002—the only use of Botox accepted by the United States Food and Drug Administration 
(FDA) was for “crossed eyes and abnormal muscle spasms of the eyelids.”34   
1.6.1.4 Treatment procedure 
Treatment with botulinum toxin A involves a simple procedure. The toxin is injected into the 
facial muscles. Within a few hours, it begins to attach to the nerve endings of the motor 
muscles, blocking the transmission of signals from nerves to these muscles.35 As ‘dynamic 
wrinkles’ result from the contraction of muscles under the skin36, when these motor muscles 
are unable to contract37 they become smooth.38 Full efficacy is reached within two to ten days.39 
                                                 
26 Ibid.  
27 P Nayyar, P Kumar, PV Nayyar & A Singh ‘BOTOX: Broadening the Horizon of Dentistry’ (2014) 8(12) 
Journal of Clinical and Diagnostic Research 25 – 29. 
28 Ibid. 
29 Ibid. 
30 Ibid.  
31 Ibid. 
32 Ibid.  
33 S Srivastava, S Kharbanda, U S Pal & V Shah ‘Applications of botulinum toxin in dentistry: A 
comprehensive review’. (2015) 6 National Journal of Maxillofacial Surgery 152- 9.  
34 P Nayyar, P Kumar, PV Nayyar & A Singh ‘BOTOX: Broadening the Horizon of Dentistry’ (2014) 8 
(12) Journal of clinical and diagnostic research ZE25-29.  
35American Academy of Facial Aestheics: ‘Frown Lines and how Botulin Toxin can help’, available on  
https://www.facialesthetics.org/frown-lines/, accessed on 23 November 2018.  
36 M Naumann, A Albanese & F Heinen ‘Safety and efficacy of botulinum toxin type A following long-term use’ 
(2006) 13(4) European Journal of Neurology 35- 40. 
37 Ibid. 




The patient experiences no loss of sensation during treatment with Botox.40 The effects of 
Botox last for around three to four months, depending on factors such as the dose of toxin 
administered and the patient’s metabolism and lifestyle choices.41 When the wrinkles begin to 
reappear another treatment can be administered. 
Before administration of Botox, the doctor should review the patient for any possible adverse 
side effects that may occur and notify the patient of all treatment options available. The doctor 
must then obtain voluntary consent from the patient detailing all the information which the 
patient needs to know. The consent form must be secured and evidenced by the signatures of 
the patient, the doctor and a witness.42  
1.6.2 Side effects 
While Botox is widely used, it is not without side effects. These may include acute pain, 
ischemia, bruising, swelling, local muscle weakness, fever and flu-like symptoms, as well as 
muscle atrophy after prolonged use, heart palpitations, tingling sensations and nausea.43 Side 
effects are rare, however, and typically disappear within one to two days.44 Allergic reaction to 
the botulinum toxin and an existing infection are contraindicated for the administration of 
Botox.45 The administration of Botox has serious adverse effects in pregnancy, lactating 
mothers and patients with neurological disorders. The toxin is further contraindicated in cases 
of flu, colds, infection and dermatitis.46  
 
1.6.3 Cosmetic use of Botox to mitigate physiological changes resulting from 
aging 
  1.6.3.1 The effects of aging on facial bone, muscle and fat 
                                                 
40 American Academy of Facial Aestheics: ’Frown Lines and how Botulin Toxin can help’, available on 
https://www.facialesthetics.org/frown-lines/, accessed on 23 November 2018. 
41 American Academy of Facial Aestheics: ’Frown Lines and how Botulin Toxin can help’, available on 
https://www.facialesthetics.org/frown-lines/, accessed on 23 November 2018. 
42 Kyung-Soo Park, Chi-Heun Lee, and Jung-Woo Lee ’Use of a botulinum toxin A in dentistry and oral and 
illofacial surgery ’   ( 2016 )  16(3)  Journal of Dental Anaesthesia and pain medicine 151-157. 
43 A Sinha A, M  Hurakadli,PYadav. ‘Botox and derma fillers: The twin face of cosmetic dentistry.’  (2015) Int 
J Contemp Dent Med Rev.  27. 
44 Ibid. 
45 ‘BOTOX’ (Onabotulinum toxin A) Medication Guide: Initial U.S Approval. (1989) , available at  
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103000s5215lbl.pdf , accessed on 12 May 2018. 
46 Ibid.  
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Throughout the ages, beauty has been associated with a youthful appearance.47 Facial bone 
structure has an immense influence on a person’s physical appearance.48 A significant 
component of a youthful appearance is a fine facial skeleton that is well supported. In youth, 
the bone structure is defined by full, high cheeks, distinct brow bones and reduced depression 
in the orbital region.49 Youthful skin is defined by softness, suppleness, smoothness and 
hydration.50  
Aging occurs at every layer of the facial structure, affecting bone, muscle, fat-pads and skin.51 
The effects of the progression of aging are more profound than the facial wrinkles and lines 
which appear on the skin. The facial bone composition is responsible for shaping an 
individual’s distinctive facial structure and contours.52 While the facial skeleton continues to 
grow throughout a person’s life,53 selective resorption takes place in targeted areas of the facial 
bone as part of the aging process.54 There are specific areas that are susceptible to bony 
resorption in the human facial bone structure and these relate to the obicularis oculi which 
cover the lateral brow, the lateral orbital ‘crow’s feet’ areas and the inferolateral orbital rim.55 
In addition, the movement necessary for the functioning of the specific facial areas is 
anatomically linked to a reduced ligamental attachment of the soft tissues to the bone. This 
means that the joining of the “muscles and ligament to the bone” in these regions experiences 
less stress.56 The absence of stress may influence bone loss in these regions. Bone loss alters 
the size and contours of the face, enlarging the peri-orbital areas, decreasing the angle of the 
brow bone and lessening the sculpture of the mandible.57 
The width and area of the orbital aperture increases with age.58 Kahn and Shaw found 
substantial decline of the contralateral aspects of the orbital rim in conjunction with aging for 
                                                 
47 S  Lanigan ‘Anti Aging Treatments Don’t Need Knife’, available at  http://EzineArticles.com/expert/ , 
accessed on 4 May 2018. 
48 Ibid.  
49 Ibid. 
50 Ibid. 
51 ‘Facial Structure: Understanding how the face ages,’ available at https://www.sfbaycosmetic.com/skin-
tightening/facial-structure-understanding-face-ages/, accessed on 12 April 2018.  
52 Ibid. 
53 B Mendelson, CH Wong ‘Changes in the facial skeleton with aging: implications and clinical applications in 
facial rejuvenation’ (2012) 36 (4) Aesthetic Plastic Surgery 753-60.  
54 Ibid.  
55 Ibid.  
56 Ibid.  
57 Ibid.  
58 DM Kahn & RB Shaw Jr ‘Aging of the bony orbit: A three-dimensional computed tomographic study’ (2008) 
28 (3) Aesthetic Surgery Journal 258-264. 
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both men and women.59 This results in recession of those particular areas, although the changes 
transpire at different rates. During middle age, there are signs of the inferolateral orbital rim 
and recession of the superomedial quadrant. There is further recession of the inferomedial 
quadrant of the orbit in old age, primarily amongst males.60 Mendelson & Wong  found that 
the superomedial and inferolateral orbital areas have the highest affinity to resorb during orbital 
aging.61 
The medial together with middle third of the facial skeleton is made up of the maxilla, and the 
lateral third of the facial structure includes the body and arch of the zygoma.62 Resorption of 
the bone in the mid-section of the face does not occur at a constant rate. The jaw bone has a 
higher tendency toward age-related loss than the zygoma.63 Mendelson & Wong note that 
deepening of the jaw bone (maxilla) results in “posterior positioning of the nasolabial crease 
and the upper lip.”64  The jaw continues to enlarge with age.65 The changes that occur in the 
bony ‘foundation’ which supports the nose in youth, the bone in the nasal area and the 
ascending processes of the maxilla precipitate changes in the soft tissue in the nose area with 
age.66 
Facial bones provide a foundation for muscle, fat-pads, and skin on the face.67 Enlargement of 
the peri-orbital bone structure results in greater prominence of the medial fat pad, elevation of 
the medial brow and lengthening of the lip–cheek junction, resulting in ‘crow’s feet’.68 The 
facial muscles which lie below the facial fat pads are in repetitive movement as one eats, laughs, 
smiles, and frowns.69 The aging process results in facial fat loss and this, coupled with gravity 
and repeated muscle movement, may lead to deep facial wrinkles.70 This results in the 
formation of ‘crow’s feet’ at the outer corners of the eyes and the formation of creases between 
the brows.71  
                                                 
59 Ibid.  
60 Footnote 53 supra. 
61 Footnote 53 supra. 
62 Footnote 53 supra. 
63 Footnote 53 supra.  
64 Footnote 53 supra. 
65 Footnote 53 supra.  
66 Footnote 53 supra. 
67 ‘Facial Structure: Understanding how the face ages,’ available at  https://www.sfbaycosmetic.com/skin-
tightening/facial-structure-understanding-face-ages/, accessed on 6 May  2018.  






Studies show that the facial muscles weaken with the passage of time.72 Loss of muscle tone 
and thinning skin may contribute to a flaccid, drooping look to the face where the jaw line loses 
its contour and leaves a less distinct profile.  Sagging can also occur as a result of the skin’s 
failure and loss of ability to recoil as it did in youth.73 The fat pads which provide volume, 
facial contour and fullness become thinner and move downwards as one ages. The loss of facial 
glands leads to decreased oil production in the skin.74A previously firm and rounded face, 
which epitomised youthfulness, begins to show noticeable changes such as hollows which may 
form below the eyes, deeper lines around the nose and mouth, flaccid skin due to a drooping  
jaw line, and a double chin caused by fat beneath the chin.75 The resulting changes in 
appearance, such as sunken eyes and sagging skin, contribute to the formation of marked lines 
around the nose and mouth.76  The loss and descending movement of fat pads can cause the 
face to look shrunken and hollow in the cheek area.77 
1.6.3.2 Prevention and treatment modalities 
Literature suggests that methods intended to control or prevent aging were in existence in 
ancient human civilisations.78 Anti-aging treatments were used in ancient Egypt by Cleopatra, 
the Egyptian queen and ruler, who cleansed her skin with donkey’s milk.79 In the seventeenth 
century, Elizabethan women used raw meat whilst the French used red wine to reduce 
wrinkles.80 Egg whites were applied to the skin as skin exfoliators.81 Most of these methods for 
slowing down the aging process did not prove to be beneficial in the long term, however.  
Anti-aging treatment modalities include both prevention and treatment. Preventative medicine 
focuses on lifestyle modification such as avoidance of pollution, radiation, smoking and 
improved nutrition and exercise.82 Treatment choices include cosmetological care, which 







78 MA Flatt,  RA Settersten, Jr, R Ponsaran, &JR. Fishman ‘Are “Anti-Aging Medicine” and “Successful Aging” 
Two Sides of the Same Coin? Views of Anti-Aging Practitioners’ (2013) 68 (6) The Journals of gerontology: 
Series B 944-55.  
79  ‘Curious History,’ available at  https://www.curioushistory.com/ancient-egyptian-beauty-secrets-of-queen-
cleopatra, accessed on  23 November 2018.  
80 GA Bubenik & SJ Konturek ‘Melatonin and Aging: Prospects for Human Treatment’ (2013) 68(6) The Journals 
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include daily skin care, sun protection and aesthetic non-surgical procedures.83 Topical agents 
such as cell regulators and systemic agents such as hormone replacement therapy and 
antioxidants are also used.84 More invasive procedures are also available, which include 
chemical peels, visible light therapy, ablation procedures, radio frequency, injectable bio-
stimulation and rejuvenation, redistribution and restoration of fat and volume loss and skin 
enhancement and shaping.85One of the most controversial treatment modalities is the use of 
botulinum toxin, commonly known as ‘Botox’.86  
1.6.4 Dental applications for Botox  
The use of Botox has been extended to dentistry where it has been found to be an effective and 
less invasive procedure for both aesthetic dental conditions, such as deep nasolabial folds, 
radial lip lines, high lip line and black triangles between teeth, as well as in the management of 
disorders of the mouth and its underlying structures, such as temporo-mandibular disorders, 
bruxism, clenching and masseter hypertrophy.87 Botox has been used to correct the 
parafunctional clenching, extra-capsular temporomandibular disorder (TMJ), trismus and 
headaches which accompany these conditions.88 A number of studies have documented the 
efficacy of Botox in patients with hemi-masticatory spasm.89 Botox is also used in orthodontic 
cases where facial muscles need to be retrained.90  Botox can be used for dental implants and 
surgery and, in cases of gummy smile, masseter enlargement, and various myofacial pains.91 
Freund and Schwartz found that whilst treating patients for facial lines with Botox injections 
there was marked recovery from migraine symptoms among patients who had received dismal 
results using traditional methods.92 
As dental surgeons receive extensive training in the anatomy of the facio-maxillary region, 
minimal training is required to make use of Botox while substantially increasing the range of 
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invasive procedures at their disposal.93 The application of Botox for dental treatment is gaining 
momentum and Botox is viewed by dentists worldwide as relatively safe for use.94 
1.6.4.1 TMJ, bruxism and pathological clenching 
One important application of Botox is as an accessory in cases of temporomandibular joint 
(TMJ), bruxism and pathological clenching, especially for those who are affected by chronic 
TMJ and facial pain. Intensive night clenching or grinding of teeth, which in acute cases may 
appear as dystonic bruxism, leads to TMJ dysfunction and, in addition, can result in damage to 
teeth, bone, joints and gums.95 In untreated cases of excessive pathologic clenching, the 
resultant fracturing of the enamel may result in tooth decay and recession of the gums.96 
Because parafunctional clenching results in periodontal trauma, restricting biting forces before 
and after pre-periodontal surgery can be vital to the healing process.97 Pathological clenching 
can be reduced by administering small quantities of botulinum toxin Type A.98   
Bruxism is a disorder characterised by excessive eccentric grinding of the teeth which can 
impact the involved muscles and may also lead to the development of TMD which, in turn, 
may result in joint impairment.99 Chronic patients present with headaches, bruxism-induced 
TMJ derangement or arthritis and find it difficult to speak, swallow, or chew.100 The condition 
is exacerbated by factors such as fatigue, stress and emotional distress.101 If sleep bruxism is 
evident, an intra-oral guard may be required to protect the teeth, however such an occlusal 
covering appliance only halts the bruxism for an interval, providing temporary relief from 
headaches and bruxism-induced TMJ derangement or arthritis.102 Due to the many appearances 
of bruxism, standard treatments which are available have irregular results and do not show 
universal success.103 Botulinum neurotoxin has exhibited great potential in minimising bruxism 
symptoms.104 As Botox is a muscle relaxant, a relatively low dose can achieve substantial 
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reduction of the severity of muscle contractions causing TMJ and facial pain, alleviating pain 
significantly in patients with TMJ who otherwise would have undergone full mouth 
reconstructions.105 
      Temperomandibular joint dysfunction (TMD) is caused by dysfunction of the muscles required 
for chewing, resulting in a litany of chewing and digestive disorders106 as well as pain in the 
facial area, around the joints, the area adjacent to the ears and radiating into the neck.107 Disease 
of the occlusion and the periodontium having an aetiology in dysfunction of the muscles of 
mastication are the fundamental constituents of temperomandibular dysfunction.108 Common 
factors of TMD include muscular spasticity, which is associated with bruxism, mandibular 
dystonia, external stresses and psychomotor behaviours, among others.109 As extra-capsular 
TMD is often temporary, the least invasive management options are preferable, however most 
of the methods currently in use are minimally effective.  If mild relaxation of the muscles can 
be achieved, the reflex action of clenching can be completely avoided without affecting the 
patient’s ability to chew and swallow.110 The masticatory musculature treatment approach of 
TMD has been limited to supportive care. In more acute cases, interventions by 
physiotherapists, oral medication and other management methods have been used but these 
usually achieve temporary and insufficient relief. 111Prolonged use of oral medication is 
unsuccessful because of the modest progression and regular side effects.112  Muscle relaxants 
such as diazepam can limit patient activities. However, for patients who have not been 
successful with the usual treatment techniques, the administration of Botox injections into the 
aching masticatory muscles can offer relief of difficult symptoms.113  
 
1.6.4.2 Masseteric hypertrophy 
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Dental patients who habitually clench their jaws tend to suffer more often from masseteric 
hypertrophy.114 The enlargement of the muscles manifests in the appearance of the patient’s 
face: for example, the jaw may look inflamed and distorted. Traditional treatment methods 
entail a surgical resection which frequently results in extensive contraction.115 A number of 
studies have found, however, that small quantities of Botox injections into the masseter muscles 
were effective in reducing masseter hyperactivity.116 
1.6.4.3 Gummy smile 
The exposure of excessive gingival tissue in the maxilla when smiling, a condition which is 
referred to colloquially as a ‘gummy smile’, is a health and aesthetic issue which is not easily 
treated.117 Excessive gum display occurs when there is over-contraction of the upper lip 
muscles, in particular the levator labii superioris alaeque nasi.”118 Procedures that have been 
developed  for the treatment of hyper-functional upper lip elevator muscles, such as the 
Rubinstein and Kostianovsky, Miskinyar and Rees and Latent techniques,119 have not proven 
successful in the management of this condition. The most frequent methods presently used are 
the LeFort I maxillary osteotomy, used in cases of impaction for skeletal vertical maxillary 
excess, and the gingivectomies for delayed passive dental eruption with excessive gingival 
display.”120 A less invasive method is preferable to reduce muscular over-contraction.  
If administered in small doses, Botox has been found to uniformly compromise these muscles, 
decreasing the extent of the gummy smile. In a study conducted by Polo, five patients with 
intense gingival display due to hyper-functional upper lip elevator muscles were treated with 
Botox under electromyographic guidance.121 Each patient was administered 0.25 U injections 
per muscle on both sides into the levator labii superioris, superioris labii alaeque nasi, and at 
the overlap areas of the levator labii superioris and zygomaticus minor muscles.122 The average 
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increase in upper lip length upon smiling was 124.2%; the duration of the effect ranged from 3 
to 6 months and no negative effects were observed or reported during this time.”123 The patients 
were content with the results.124 
1.6.4.4 Dermal filler therapy 
Another significant application of Botox is its use in tandem with dermal filler therapy as a 
non-invasive alternative in treatment of high lip-lines.125 Dental training includes a surgical 
procedure that involves the periodontal flap.126 When using Botox therapy and lip enhancement 
with dermal fillers, the muscles around the lips become weakened, limiting the elevation of the 
lip while retaining complete function.127 This process must be carried out carefully to ensure 
that the patient maintains adequate lip proficiency for speech, eating and facial expression.128 
An advantage of treatment with Botox and dermal fillers is that results can be achieved nearly 
instantly in one session, with no extraction.129 The shortcoming is that treatment must be 
repeated two to three times annually and the costs are excessive.130  
1.6.5 Regulatory context for dental application of Botox in South Africa 
In South Africa, dentists are required to register with a number of statutory bodies, including 
the Health Professions Council of South Africa (HPCSA), the South African Dental 
Association (SADA) and the Dental Ombudsman. These statutory bodies govern the scope of 
dental practice, thus protecting the interests of the patient. Section 22A (5) (f) of the Medicines 
and Related Substances Act131 states that a practitioner, nurse or a person registered under the 
Health Professions Act132, “other than a medical practitioner or dentist, may prescribe and 
apply, only within his/her scope of practice and subject to the indication for the use of such 
substances and medicines and to the conditions determined by the Medicines Control Council, 
to patients under his/her care.”   
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Dentists who act beyond the scope of their training are subjected to disciplinary action such as 
suspension from practice, dismissal or criminal charges.133 As Botox treatment is not 
specifically addressed in the training of dental surgeons, this raises the question whether the 
administration of Botox can be considered to fall within the scope of a dentist’s qualification 
or not.  
The South African Health Professions Act 56 of 1974, section 33(1), read with section 61(2), 
of the Health Professions Act (Act No. 56 of 1974) as amended by Act 29 of 2007, sets out the 
scope of practice of the dentist as follows: 134 
 (a) The physical clinical examination of the oral, maxillofacial and related 
structures of a person; 
 (b) making a diagnosis of diseases, injuries and conditions of the oral, 
maxillofacial and related structures, including determining the relevance of 
systemic conditions, and/or giving advice on such conditions; 
 (c) performing dental procedures and/or prescribing medicines aimed at 
managing the oral health of a patient, including prevention, treatment and 
rehabilitation; 
(d) performing any procedure on a patient aimed at fitting or supplying a dental 
prosthesis or appliance; and 
 (e) performing any aesthetic or cosmetic procedure on a patient pertaining to 
the oral and perioral area.135 
1.6.5.1 Limitation of administration of Botox to specific health care practitioners 
According to the Health Professions Council of South Africa (HPCSA) Guidelines (Addendum 
2) of the Medicines Control Council of South Africa, scheduled substances used for cosmetic 
medical procedures may only be administered by a doctor or other qualified professional 
registered with the HPCSA who is adequately trained in the relevant anatomy, physiology and 
pharmacology, including the management of potential side effects and complications.136 
Administration of scheduled substances to patients by non-registered persons is deemed illegal 
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and is grounds for criminal prosecution.137 What is not clearly established is whether dental 
surgeons fall within the ambit of adequately qualified medical professionals or not. 
1.7 Medical malpractice and or negligence 
Medical malpractice may be defined as bad or wrong practice resulting in loss of limb by 
amputation, deformity, serious injury to health, or even death.138 Medical malpractice is a far 
more expansive term than medical negligence because it includes negligent and intentional acts 
or omissions.139 ‘Medical negligence’ refers to the failure of practitioners to perform with 
adequate competency in their sphere of the profession.140 ‘Negligence’ signifies conduct and 
relates to how practitioners use their minds to execute what they know to be illegal.141 
Negligent acts or failure to act which can result in criminal prosecution include performing an 
operation and causing brain damage to a patient or failing to obtain informed consent from a 
patient.142 Intentional acts or omissions that may result in legal recourse include knowingly 
breaching confidentiality or otherwise violating a patient’s privacy, or intentionally failing to 
obtain an informed consent, which is classified as ‘assault’.143 The question of whether or not 
a patient was issued an informed consent is regularly highlighted in cases of medical 
malpractice and medical negligence.144 
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CHAPTER TWO: THE LEGAL FRAMEWORK GOVERNING THE 
ADMINISTRATION OF BOTOX BY DENTISTS IN SOUTH AFRICA 
2.1. Introduction 
The previous chapter provided an introduction to this thesis. It provided the background to the 
study, deliberated on the academic views and studies on Botox and described the research 
questions. The literature indicates many of the complexities of administrating Botox, including 
legal issues. This chapter addresses the legal framework governing the administration of Botox 
in South Africa, the standard of dental care, medical malpractice and informed consent.  
According to the Health Professions Council of South Africa, Act 56 of 1974, section 33, the 
scope of practice of the dentist entails the following;1 
 (a) The physical clinical examination of the oral, maxillofacial and related structures of a 
person; 
 (b) Making a diagnosis of diseases, injuries and conditions of the oral, maxillofacial and 
related structures, including determining the relevance of systemic conditions, and/or giving 
advice on such conditions; 
 (c) Performing dental procedures and/or prescribing medicines aimed at managing the oral 
health of a patient, including prevention, treatment and rehabilitation;  
(d) Performing any procedure on a patient aimed at fitting or supplying a dental prosthesis or 
appliance; and 
 (e) Performing any aesthetic or cosmetic procedure on a patient pertaining to the oral and 
perioral area.2 
 
Dentists who practice outside this scope of their dental license are in violation of the Health 
Professions Act3 and the HPCSA regulations.4 Medical malpractice involves all acts that are in 
violation of not only the law but medical practice in general as prescribed by the HPCSA.5 
Medical malpractice includes delayed diagnosis and is the most common reason for claims 
against registered practitioners. It includes failure to diagnose, exclusion of revision of an 
                                                 







incorrect diagnosis even when new evidence is produced, examined or investigated. The 
underlying factor is evident in the break in communication, either with the patient or with 
colleagues, or all parties. The quantity and cost of clinical negligence claims in South Africa 
has been escalating at a rapid rate.6A doctor  does not only stand to face a civil claim if his or 
her practice fails to meet the required standards but may also undergo disciplinary proceedings 
initiated by the Health Professions Council.7 
The HPCSA identifies the following acts as forms of medical malpractice: unlawful 
advertising; over-servicing of patients; criminal convictions; engaging in an inappropriate 
relationship with a patient; unacceptable behavior; conducting a procedure without a  patient’s 
informed  consent; releasing information about a patient without his or her authorization; 
managing a patient incompetently; demanding exorbitant remuneration for services provided, 
inadequate patient care; demonstrating racial prejudice; insolence to patients; writing 
prescriptions for patients who are habitual drug users; perverse incentives; accepting bribes; 
and treating intoxicated patients.8 
2.2. Medical malpractice in relation to the administration of dental Botox: 
Negligence and application by the courts 
3. There is no law presently in South Africa which specifically addresses legal claims in the 
medical field; claims established on the grounds of medical negligence or malpractice are thus 
dealt with under common law.9 Medical malpractice can lead to a common law delictual claim 
for damages in terms of South African private or civil law.10  
4.  
It is important to clarify the difference between medical malpractice and medical negligence. 
Medical malpractice is defined as “any act or omission by a physician during treatment of a 
patient that deviates from the accepted norms of practice in the medical community and causes 
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an injury to the patient.”11 As such, malpractice is the umbrella term that encompasses both 
intentional and negligent conduct by a medical practitioner that causes injury or harm to a 
patient, including acts or omissions. Negligence, on the other hand, arises when a medical 
practitioner performs his or her job in a way that differs from this approved and appropriate 
medical standard of care.12 If a patient suffers damage or loss resulting from a doctor or 
hospital’s failure to take reasonable care, the doctor or hospital may be found liable for 
negligence.13 Medical negligence is considered medical malpractice when the medical 
practitioner’s negligent treatment causes unwarranted injury to the patient; for example, if it 
worsens the patient’s state of health, initiates unnecessary and unforeseen complications or 
requires further medical treatment.14  
 
 
2.2.1 Medical malpractice  
Medical malpractice arises when a health care professional neglects to administer proper 
treatment, excludes the correct action, or provides substandard treatment that culminates in 
danger or injury to a patient or results in the patient’s death.15 Under the law of delict, doctors 
and hospitals have a duty to provide acceptable care to eliminate any harm to their patients.16 
South Africa derives its medical malpractice law from English common law which forms the 
basis of jurisprudence in most Commonwealth countries and in the United States.17 Common 
law refers to law that is established by precedent in court cases rather than through a legislative 
process.18 As such, this section will refer to case law on delictual claims on medical 
malpractice.  
It is important to note that a doctor or hospital that deliberately breaches a patient’s 
confidentiality may be deemed liable for injuria.19 In South African law, the medical doctors 
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may encounter liability if they do not properly implement their legal duty towards a patient, 
resulting in harm. 20 The negligent conduct of the medical doctor will result in delictual 
liability if all the elements of delict are met. The elements of delict are harm, conduct, 
causation, fault and wrongfulness.21All these elements must be proven for medical 
malpractice. 
  
In the context of dentistry, malpractice includes the breach of confidentiality, the failure to 
receive valid informed consent, the issue of fraudulent medical certificates, claiming for 
unrendered medical services and not abiding by regulations which govern the dental profession. 
22 The failure to adhere to norms and standards of the dental profession is the major cause of 
malpractice together with the failure to obtain the desired therapeutic goals.23 Thereafter, it 
must be demonstrated that the dentist had a license to practice, as this would mean that they 
had a professional obligation to render appropriate care to the patient. If a surgeon was found 
to be unlicensed, this would constitute a criminal offence. Secondly, it must be shown that the 
dentist failed to discharge their professional duty through error and substandard care. Thirdly, 
it must be demonstrated that this error resulted in injury; and, fourthly, that the injury led to 
damages.24 The damage may be physical harm, such as scarring, injury to teeth and or oral 
structures, permanent loss of teeth or disability, or could involve other costs, such as lost 
productivity at work and wages or emotional trauma.25 
The case law which has the greatest relevance for medical practitioners is obtained from civil 
claims declaring medical negligence; the most relevant of these are those that define a violation 
of duty of care or causation.26 In a negligence claim, the plaintiff will succeed on a balance of 
probabilities that the defendant failed in a presumptuous duty of care that was owed by the 
defendant to the plaintiff and there was a violation of that duty which resulted in harm.27 For 
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delictual claims, the court requires a complainant to prove that the actions of the defendant 
were not seen as being reasonable in accordance with the law.  
In the case of dental Botox, the court would need to determine that the treatment of dental 
problems using Botox was conducted properly, within the scope of dentistry and in accordance 
with the prescribed guidelines of the Health Professions Council. If that the first criterion is 
confirmed (which is usually the case), the plaintiff must then render persuading evidence that 
the healthcare professional involved could reasonably have foreseen the consequences of his 
or her action and did not protect against such an eventuality; moreover, it must be shown that 
the practitioner’s actions fell short of the standards that the law considers reasonable. The test 
for reasonable conduct was set out in the judgment of a 1924 case where it was argued that it 
does not always follow that a breach of duty of care results in harm to a patient.28  There may 
be situations in which the outcome would have been the same for the patient whether the breach 
of duty to care had transpired or not. For example, a diagnostic delay in a present incurable 
tumor is unlikely to influence patient outcome. This is where the testimony and evidence by 
proficient witnesses is critical for contending the causation constituent of a claim. What it often 
leads to is if the judge chooses one expert’s view over another’s.29 In deciding what is 
justifiable, the court will have to consider the skill, expertise and conscientiousness held and 
used at any time by the members of the professional body to which they belong.30 This also 
extends to the branch of dental Botox. This means that if a doctor’s treatment of a patient is 
regarded as justifiable by the regulatory association of his or her colleagues, or through the 
testimony of a practitioner in his or her capacity as an expert witness before the courts, a court 
would be unlikely to find him or her guilty of negligence.  
The question arises whether, in the case of dental Botox, a surgeon or a dentist can be 
considered an expert witness by the courts. Based on the theory of the scope of practice in the 
administration of dental Botox, a dental surgeon may provide expert testimony as an expert 
witness provided that the practitioner administered the Botox in accordance with the scope of 
practice for dentists. If, for instance, the Botox was administered by the dentist outside the peri-
oral region, the dentist would be assessed against the standards of a practitioner who is 
authorised to administer Botox in these areas of the body, such as a plastic surgeon. The expert 
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witness, in that case, would be a plastic surgeon. The plaintiff’s case would only be successful 
if the court found that a contravention of duty caused harm to the patient.  
The quantity and cost of clinical negligence claims brought in South Africa has escalated in 
recent years.31 General practitioners who conduct surgery should be aware that they are more 
prone to legal action and must proceed with caution. In cases of an emergency they should only 
take on procedures that are clinically necessitated, act within their field of competency, obtain 
informed consent and work within their scope of care.32 
In a medico-legal survey conducted in the USA concerning dental malpractice, approximately 
one-quarter of the malpractice claims reported were made on the basis of complications 
resulting from minor and major oral surgery.33 A fifth of the claims related to endodontic 
treatment. Rehabilitative procedures such as implants, crowns and bridges that resulted in 
injuries or fractures formed another quarter of the complaints. The rest of the complaints dealt 
with complications arising with braces, severe infections and diagnostic failures.34 
The HPCSA and the Scope of the Professions of Dentistry in the Health Professions Act specify 
that, except in an emergency, a practitioner shall only execute a professional act for which they 
are suitably qualified and adequately experienced. In cases where a practitioner is not suitably 
qualified and adequately experienced, the practitioner must communicate and collaborate with 
appropriately qualified health practitioners in the management of a patient. The onus is, 
therefore, on the practitioner to ensure that they have an adequate education, training and 
experience in the implementation of any procedure.35 If they fail to meet this standard they 
could be liable if sued for medical malpractice.   
2.2.2 Medical negligence 
As mentioned earlier, one form of medical malpractice is medical negligence. Sir William 
Blackstone, an English jurist, coined the phrase ‘medical negligence’ in 1768, noting that it 
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was “how trust is broken between the patient and the practitioner”. According to Carstens and 
Pearmain, the first mention of medical negligence in South Africa was in an 1877 case in which 
Judge de Villiers defined ‘medical negligence’ as follows:  
…there can be no doubt that a medical practitioner, like any professional man, is 
called upon to bring to bear a reasonable amount of skill and care in any case to 
which he has to attend: and that where it is shown that he has not exercised such 
skill and care, he will be liable in damages.36  
Liability for omissions in the practice of medicine was acknowledged in the courts in the case 
of Kovalsky v Krige37 in which the plaintiff declared inter alia that the doctor was negligent in 
not waiting with the patient until it was safe for the patient to be left alone. The court ruled that 
a surgeon is required to demonstrate reasonable care and proficiency in patient management.38 
The case of Kruger v Coetzee 39 set an important precedent in terms of how negligence is 
handled. In this case, the court adopted the criterion of an impartial standard of the reasonable 
person. To this end the court said that, for the purposes of liability, culpa arises if: 
 (a) A diligens paterfamilias in the position of the defendant- (i) would foresee the 
reasonable possibility of his conduct injuring another in his person or property and 
causing him loss; and (ii) would take reasonable steps to guard against such 
occurrences; and (b) the defendant failed to take such steps. . . . An action for 
damages alleged to have been caused by the defendant's negligence, culpa arises, 
for the purposes of liability, only if a diligens paterfamilias in the position of the 
defendant not only would have foreseen the reasonable possibility of his conduct 
injuring another in his person or property and causing him patrimonial loss, but 
would also have taken reasonable steps to guard against such an occurrence, and if 
the defendant failed to take such steps.40 
2.3. Standard of dental care 
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2.3.1 Duty of care 
A duty refers to ‘an obligation to do’ or ‘avoidance of doing something’. If we have a duty to 
another person it means we are obligated to that person in some respect and for some reason 
while he or she holds a corresponding right or claim against us.41 According to the HPCSA, 
“duty of care encompasses duties to patients, colleagues, and other health care practitioners, 
duties to themselves, duties to society, the health care profession and lastly, duties to the 
environment.”42 The broad  principle of duty of care to the patient entails taking into 
consideration the best interests and wellbeing of the patient; acting with objectivity and 
integrity; providing secure access to care; treating the patient with respect; involving the patient 
in the management of his or her health; upholding the patient’s privacy; obtaining informed 
consent, and preventing conflict of interest.43 
In the context of dentistry, an important aspect of duty to care is the use of extreme caution in 
the administration of medicines or drugs which may have adverse effects or be contraindicated 
for patients.44 Patel advises that dentists should avoid administering Botox to mentally unstable 
patients or patients with unrealistic expectations and that in the event that a dentist decides to 
treat such a patient, they should proceed with extreme caution. 45 Barbano recommends that 
Botulinum A should not be administered to patients such as celebrities or actors whose 
livelihood is linked to some extent to their physical appearance, because contraindications or 
side effects of the drug could potentially alter their appearance in undesirable ways.46 In 
addition, Patel proposes that Botox should not be used in dental or cosmetic surgery for the 
following categories of patients without extreme caution: 47  
i. Patients with neuromuscular disorders (e.g. myasthenia gravis, Eaton-Lambert 
syndrome) and who have allergies  and allergic to any of the constituents of 
Botulin Toxin A or Botulin Toxin  B (i.e. BTX, human albumin, saline, 
lactose and sodium succinct). 
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ii. Patients who are on medications which can affect the neuromuscular impulse 
transmission and exacerbate the effects of BTX (e.g. amino glycosides, 
penicillamine, quinine, and calcium blockers). 
iii. Pregnant patients or lactating mothers (BTXs are classified as pregnancy 
category C drugs) 
Providing an adequate standard of care to dental Botox patients involves prioritising each 
patient’s interests, listening carefully to their wishes or concerns and considering their 
preferences.48 Also, patients have expectations of being regarded as individuals and having 
their cultures and values respected and expect that all members of the dental team will possess 
honesty and reliability. 
Dentists administering dental Botox need to ensure that they have considered all aspects of 
their patients’ health and well-being.49 Standard of care for Dental Botox patients also involves 
treating patients in a hygienic and risk free setting, coupled with sound corrections or 
alterations for any disabilities. Furthermore, dentists practicing dental Botox need to put the 
interests of their patients first before financial gain and business need.50 Standard of care further 
extends to managing dental pain and anxiety appropriately and providing redress to patients 
who suffer harm during dental treatment. Patients require information which is complete, well 
defined and precise before, during and after care in order to make informed decisions.51 Patients 
require proper details of the treatment, possible results, costs and any changes likely to occur. 
The standard of care also includes a dentist being able to keep patients’ records updated, 
complete, distinct, precise and readable. This includes ensuring that the personal information 
of their patients are kept confidential; failing to do so represents medical malpractice.52 
2.4. Negligence 
People of the State of California v. Conrad Robert Murray53 
In 2011, Dr Conrad Murray was sued for "grossly negligent and reckless behaviour" after he 
allegedly administered harmful doses of the anaesthetic Propofol to popstar Michael Jackson, 
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resulting in his death.54 In this case, Murray’s administration of the anaesthetic outside of the 
clinical setting and without appropriate monitoring facilities and equipment was considered by 
the court to be “direct evidence of wilful reckless conduct.”55 The court ruled that Murray did 
not give adequate consideration to the risks related to the administration of anaesthesia outside 
of an appropriate clinical setting; i.e. a hospital. Such conduct, under criminal law, can be 
regarded as “reckless and a gross deviation from the standard of care.”56 Following a six-week 
trial, the jury found Murray guilty of involuntary manslaughter. He was sentenced to four years 
in prison but served two years in prison.57 This prominent case determined that recklessness in 
medical practice must be criminally prosecuted.  
2.4.1 Administering Botox outside of the dental scope of practice  
A dentist may be deemed negligent if they administer Botox outside of their scope of practice. 
In South Africa, Botox is scheduled as a prescription-only drug. It must be prescribed and 
administered by an appropriately trained and qualified doctor.58 It is therefore illegal for a 
person who does not have the requisite qualification, skills and knowledge to administer Botox. 
As a neurotoxin, Botox can have serious harmful effects if used incorrectly.  
In the United Kingdom (UK), registered dentists are recognised as “appropriate practitioners” 
and are permitted under Section 58(2) of the Medicines Act to “procure, prescribe, dispense or 
administer, prescription-only medicines (POMs) in connection with the practice of dentistry.”59 
Botulinum toxin is one such medicine. By specifying that these activities are allowable within 
the practice of dentistry, the General Dental Council (GDC) in the United Kingdom may have 
had the effect of preventing registered dentists from procuring, supplying, administering or 
dispensing products containing botulinum toxin when they are using these products for 
cosmetic purposes beyond the practice of dentistry, rather than therapeutically as part of dental 
treatment.60 The GDC’s long-standing guidance, as set out in the ‘Red Book’ and later in 
Maintaining Standards, had always made it clear that registered dentists who prescribed drugs 
for patients other than in connection with the ‘above board’ course of dental treatment  were 
liable to be found guilty of serious professional misconduct.61 The fine detail of this specific 
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guidance was lost in the transition to the Standards for Dental Professionals,62 but in the 
Council’s latest October 2013 guidance on prescribing Medicines in its Standards for the 
Dental Team its position is described as follows:63 
 Dentists must not remote prescribe (for example via telephone, email, or a 
website) for non-surgical cosmetic procedures such as the prescription or 
administration of Botox or injectable cosmetic medicinal products.64 
2.4.2 Administering Botox in dentistry while lacking adequate competence 
According to the HPCSA guidelines, dental Botox needs to be practiced by a registered 
specialist who has received training from an examination body accredited by the Board.65 It is 
therefore medical malpractice for a dentist to delegate the administration of Botox to a 
practitioner without the requisite competencies.66 In the case of the South African Dental 
Association v Minister of Health,67 the court declared that it was illegal for a qualified dentist 
to delegate his or her duties, especially when specialist skills and medicine were involved, to 
dental assistants. In a challenge where the South African Dental Association (SADA) sought 
to legalise the exception to the general rule to have dental assistants recognised as 
professionals, SADA argued that the traditional practice of training dental assistants in the 
workplace adequately equipped them to prescribe dental medicines and conduct surgery. 
SADA argued that as dental assistants assist dentists extensively with dental procedures that 
require contact with patients they acquire the necessary expertise to perform some procedures 
without supervision. The court dismissed the case with costs and maintained that dental 
assistants may only perform specialist procedures such as dental surgery, including the 
administration of Botox, in the presence and under the guidance of a qualified, experienced 
and registered dentist. The court further maintained that the role of dental assistants must be 
restricted to the duties specified under the Health Professions Act 59 of 197468, which covers 
preparing and managing the dental clinical setting before, during and after patient care; 
sterilising medical instruments; sanitising clinical work areas; ensuring strict infection control 
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practices are adhered to; preparing dental materials and instruments (including dental hand 
pieces) to be used  in clinical techniques; assisting with patients’ requests  and care  during 
dental treatment; keeping accurate records and assessments of patients; processing radiographs; 
and assisting the dental  practitioner during dental  procedures and emergencies.69 
The outcome of South African Dental Association v the Minister of Health70 implies that it is 
unlawful for a registered and qualified dentist to delegate duties, including administering Botox 
during surgery or in another context, to an assistant. Penalties may be imposed on a qualified 
and registered dentist who delegates their duties to someone whose qualifications, skills and 
competencies are not recognised by the HPCSA to administer certain drugs – worse still, to 
perform specialised dental surgery. 
A doctor is also required to take a proper patient history. According to the Consumer Protection 
Act of 1986 in India, administration of dental Botox without thoroughly conducting patient 
medical history constitutes a segment medical malpractice.71 The Supreme Court of India, for 
example, has declared that it is imperative for a medical doctor of any speciality to conduct 
thorough investigation into the patient’s past and medical history. This will aid in supporting 
their case in the event of a claim of medical negligence.  In the case of Dr. Suresh Gupta v. 
Govt of NCT Delhi72, the Supreme Court of India stressed the importance of gathering medical 
evidence to ascertain the patient’s past and present medical history; failure to do so was 
considered medical malpractice.73 
Legally, a dentist commits medical malpractice if he or see undertakes to do a task for which 
he or she lacks professional competence. Competence does not only involve attaining a 
qualification, however, but also involves continually staying abreast of developments in the 
field and ensuring that one has the necessary skills and training to perform new or updated 
procedures.  Thus most medical professional bodies, such as the HPCSA, mandate that all of 
their members update their skills and attend continuous professional development courses in 
their areas of specialisation on a regular basis.74 In the context of dental Botox, this involves 
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dentists attending lectures and courses and staying abreast of research to ensure that their 
knowledge of developments and improvements in the administration of Botox in dentistry is 
up-to-date. Given that it is standard practice that medical practitioners continually upgrade their 
knowledge and skills in order to maintain competence, it could be argued that incompetence 
can constitute a form of negligence.  
In addition, the fact that the person performing a procedure has a recognised qualification does 
not exonerate him or her from medical liability concerning the procedure. In the sphere of 
medical law ignorance is not a defence. By keeping updated with modern trends and 
developments in the administration of Botox in dentistry, dentists are better positioned to 
minimise the potential for litigation that is related to intentional or unintentional acts 75  
2.4.3 Administering Botox in excess of prescribed limits 
As mentioned above, one way in which a dentist could be guilty of negligence is by 
administering a dose of Botox in excess of safe limits.  Botox is a neurotoxin which, if ingested, 
can interact with vital muscles in the body, causing paralysis and potentially resulting in 
fatality. When injected in minute doses into marked areas identified for Botox, however, it can 
effectively and safely inhibit signals between the nerves and muscles, effecting relaxation of 
the muscles. It is therefore crucial that Botox be administered in extremely low doses. A dentist 
commits an offence if he or she administers Botox above the prescribed limit. Thus 
administering of Botox in doses above the prescribed limit constitutes a serious form of medical 
malpractice and violates foundational tenets of medical law.76 The estimated lethal dose for 
human beings is approximately 3,000 U.77 “For cosmetic use, the typical Botox dosages should 
be less than 100 U.”  “Optimal pH of the solution is between 4.2 and 6.8, and vials should be 
stored at or below −5°C.” These guidelines needs to be strictly adhered to and failure to adhere 
to professional guidelines on dosage would be a form of negligence, as dentists are required to 
act in accordance with professional and ethical guidelines.78        
2.4.4 Failing to obtain informed consent 
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The Dental Protection Board, of which South Africa is a member, publishes statistics on 
complaints related to dental Botox for each member country.79 The four most common types 
of complaints are the following:  
 Shortcomings in the consent process; particularly, failure to adequately inform the 
patient about the expected outcomes and potential negative outcomes of the 
procedure.80 
 Dissatisfaction with the outcome of the  cosmetic procedure (often related to asymmetry 
and ‘lumping’ in the case of dermal fillers)81 
 Hypersensitive  reactions (leading, in one case, to anaphylaxis)82 
 Postoperative pain, discomfort and bruising.83 
In the case of Castell v Greef,84 the Supreme Court of South Africa established the standard of 
a “reasonable patient” when it comes to a medical practitioner’s disclosure and obtaining 
informed consent. The case involved a prophylactic subcutaneous double mastectomy and 
simultaneous breast reconstruction with the use of silicone implants involving a transpositional 
flap procedure.85 The medical procedure had a 50% chance of complication. In this case, the 
court ruled that a patient’s consent would amount to a justification to the wrongfulness and 
consequences of a medical procedure or an operation and its consequences, if the medical 
practitioner has a duty to warn the consenting patient of a material risk that comes with the 
proposed treatment; and further that such a risk is “material” if, in the circumstances of the 
particular case: (a) “a reasonable person in the patient's position, if warned of the risk, would 
be likely to attach significance to it; or (b) the medical practitioner is or should reasonably be 
aware that the particular patient, if warned of the risk, would be likely to attach significance to 
it.”86 
Glick argues that it is necessary to draw attention to the fact that the use of botulinum toxin is 
not always for cosmetic/aesthetic purposes, but also for dental procedures.87 There are many 
well-recognised therapeutic uses for this substance, not least in conjunction with the treatment 
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of temporomandibular joint (TMJ) disorders and other forms of facial pain, in special care and 
paediatric dentistry and in certain procedures within the field of oral and maxillofacial 
surgery.88 The use of botulinum toxin to reduce dysfunctional muscular activity alongside 
conventional orthodontic treatment has also been documented.89 The author further states that 
Dental Healthcare Professionals are in a more advantageous position than many other health 
care professionals to conduct these procedures risk free and with a successful outcome due to 
their knowledge and training in anatomy, physiology and pharmacology, their technical skills 
and expertise in the control of infection, and their competency to cope with a medical 
emergency.90 
Key aspects of informed consent  
(i) Information  
Informed consent requires a dentist to explain the risks, benefits and alternatives to a procedure 
to the patient. The dentist is responsible for informing the patient themself and ensuring that 
the patient understands what has been explained to them.91 Various allegations founded on lack 
of informed consent usually claim that a physician failed in his duty to provide the patient with 
all the information about the risks and possible substitutions for the recommended treatment, 
or that a physician administered treatment which was unauthorised by the patient.92 In a case 
in India, Dr. Shyam Kumar v Rameshbhai Harmanbhai Kachhiya,”93 an operation performed 
for glaucoma and cataract resulted in a weakened retina and loss of vision. The National 
Commission of India ruled that undertaking an operation without obtaining informed consent 
was improper. In this case, the medical records were not produced, and it was further decided 
that a patient cannot be deprived of such information and was entitled to claim compensation.94  
The practice of treating patients without disclosing potential risks is akin to securing consent 
of the patient by misrepresentation. In the case of Salgo v Leland Stanford University Hospital95 
in California, a patient became paralysed as a result of a new diagnostic treatment. The patient 
claimed that the doctor had failed to inform him of the risk of paralysis associated with the 
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procedure.96 In another disclosure cased in the United States, Natanson v Kline, a woman sued 
for malpractice after she suffered burns during cobalt radiation therapy following her 
mastectomy. The doctor conceded that while the patient had consented to the therapy, she had 
not been adequately informed of the risks.97  South African courts regard medical 
misrepresentation of facts to be a serious criminal offence.98  
The administration of Botox in dentistry can result in a wide range of side effects. These must 
be discussed thoroughly with prospective patients prior to obtaining consent so that they are 
able to make informed decisions about treatment with Botox. states that  
systemic side effects of administering Botox in dentistry include anxiety, 
dizziness, drowsiness, headache, dry mouth and eyes, pharyngitis, dysphagia, 
facial pain, symptoms of flu, failure to focus eyes, drooping eyelid or eyebrow, 
unclear vision, sensitivity to light, nausea, sweating, fever, chills, allergic reaction 
like rash, itching, dyspnoea, tightness of chest, facial oedema, hoarseness of voice, 
respiratory infection, anaphylaxis, urticarial, erythema multiforme, pruritus, no 
bladder control, loss of strength, paralysis and  seizures. The side effects at the 
injection site involve pain, redness, tingling, and bruising, swelling, tenderness, 
stiff or weak muscles at or close to the bleeding site.  
Informed consent involves more than adequate informing the patient of outcomes and risks and 
asking the patient to sign a consent form. The medical practitioner is obligated to disclose all 
relevant information about his or her competency and expertise to conduct the procedure or 
offer the appropriate care so that the patient is adequately equipped to make an informed 
decision. The medical practitioner is also required to accurately reflect the patient’s oral health 
care needs to the patient. The South African Dental Act states that compelling a patient to 
undergo a procedure by distorting the value of the procedure or the patient’s need for the 
financial gain of the practitioner violates trust in the patient-doctor relationship and constitutes 
medical malpractice.  
(ii)   Appreciation and agreement  
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The consent form must contain all information relevant to the procedure expressed in clear and 
simple terms. The HPCSA recommends that the consent form which has been prepared for a 
procedure should be read aloud to the patient by the practitioner.  Sillis states that the discussion 
of risks, benefits and alternatives (RBA) should be noted in a chart as “RBA discussed and 
questions answered” or “RBAQA.” To prove the discussion had taken place, dentists are 
advised to develop a custom and a practice: that is, a habit in the way they practice. While a 
dentist may have issues recalling the details of a certain case, they can communicate the typical 
protocol that they would usually employ for the procedure.99 The HPCSA advises dentists that 
although informed consent discussions differ depending on the individual requirements of a 
patient, the clinician must ensure that the nature of the recommended treatment, the risks, 
complications and benefits of the recommended treatment, alternatives to the treatment and the 
treatment plan and anticipated order of events are explained in detail to the patient.100 After the 
patient has had an opportunity to ask any questions they may have and has agreed to the 
procedure, both patient and clinician must sign the consent form.101 
Sillis describes a case in which a dentist was prosecuted for damage to the inferior alveolar 
nerve during a wisdom tooth extraction. The dentist had used a standard informed consent form 
that merely informed the patient of potential nerve during the procedure but failed to include 
the term ‘permanent injury to the nerve.’102 It was ruled that the mere inclusion of the term 
‘permanent’ would have saved him from liability.103 
In another legal matter, a patient claimed the dentist performed root canal therapy which was 
unwarranted. The teeth in question had received several restorations for persistent dental caries. 
Though the risk of pulpal involvement was possible due to the extent of the old restorations, 
the dentist failed to use a consent form nor did he note that he had communicated this option 
to the patient.104 The teeth continued to be symptomatic and necessitated root canal therapy 
and the patient proceeded with litigation. The dentist could have avoided litigation by obtaining 
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an informed consent which included the use of additional treatment up to and including 
extraction and discussing the patient’s total care with him.105 
According to the HPCSA, discussions around ‘informed consent’ are often difficult due to 
language problems. If the patient is deaf, the dentist must provide a sign language interpreter; 
if the patient speaks a language different from that spoken by the dentist the insurance provider 
must provide a translator.106 For minor children, the dentist must involve the parent in this 
discussion.  
In the USA, the cost of provision of a sign language interpreter must be covered by the dentist 
and cannot be transferred to the patient. For divorced parents, the parent with legal custody 
may give informed consent. Minors who are emancipated can give their own informed 
consent.107 
Although patients ultimately decide which treatment options to take, their signed consent forms 
are not always enough to safeguard a dentist from liability should a dentist provide care which 
is below the acceptable standard.108 Informed consent does not offer protection against 
malpractice. On the contrary, a dentist should not proceed to treat patients who persistently 
refuse the suggested treatment.109 
Making an informed decision is the right of every patient, but it is the responsibility of the 
dentists to ensure that the patient is given all of the information necessary to exercise this right 
—including information about risks, benefits and other treatment options.110  
The South African National Health Act111 states that it is a criminal offence to provide a health 
service to a patient without the patient’s informed consent. The Act protects the right of 
competent patients to consent to health services and treatment and obligates health service 
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providers to “take all reasonable steps to obtain the [patient’s] informed consent”.112 Section 8 
of the Act specifically provides that “health care users have the right to participate in decisions 
affecting their health and treatment” and, to this end, it mandates health service providers to 
share relevant information with users who lack the capacity to make decisions, unless the 
disclosure of such information would be contrary to the user’s best interests.113 
2.5. Failure to behave in a paternalistic and professional way 
The next aspect of professional behaviour is balancing paternalism with patient autonomy.114 
Paternalism implies an “authoritarian attitude,” knowing the best course of action and unilateral 
decision-making without patient involvement.115 Taking paternalism further would lead to 
assertiveness or a belief in a particular treatment regimen, withholding information about 
negative consequences of a specific treatment/procedure, compulsion, and swaying for a 
favourable acceptance from a patient who has inadequate knowledge; this is unlawful.116 
Another illegal aspect is a situation whereby dentists engage in intense marketing tactics such 
changing outcomes and benefits of dental Botox for the sake of ensuring that a patient accepts 
treatment; this is unlawful and results in professional legal liability on the part of the medical 
professional.117 
Patient autonomy refers to a patient's right to request a treatment procedure that may be against 
a clinician's will. If a patient requests a cosmetic procedure which goes against the  clinician’s 
professional judgement, the patient must be aware that they are fully responsible for the 
decision to treat, that such treatments are not bound by the ethics of medical and dental boards 
and that if any complications arise they have no recourse whatsoever.118 After the clinician 
explains the reasons for and against the procedure, it is the patient's prerogative to make a 
decision;119 the clinician, however, also has the right to refuse to perform procedures which 
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they consider a violation of professional conduct. In such a case, the patient is at liberty to seek 
treatment elsewhere.120 
As clinicians, dentists have the responsibility to prepare treatment plans that support 
‘professionalism’ (educating the patient) and ‘patient autonomy’ (respecting patient wishes), 
and are followed by scientific credibility; it is essential to ensure that the operator has the ability 
to perform and provide what is being recommended.   
2.6. Medical ethics in the context of Botox treatment 
Medical ethics is defined as “a system of moral principles that apply values to the practice of 
clinical medicine and in scientific research.” 121 Medical ethics is based on a set of values that 
professionals can refer to in situations which are ambiguous or in which a conflict of interest 
has arisen.122 Ethics encompass four primary principles: non-malfeasance, beneficence, 
autonomy, and justice.123 While ethical compliance requires that all four of these principles be 
satisfied, in reality one or more element is often given preference over the other. This may be 
due to conflicting views between a patient and clinician, with one party being more 
dominant.124 In cosmetic dentistry, ethics is usually fairly straightforward and situations often 
can be clearly judged as ‘right’ or ‘wrong’: if a decayed tooth is restored to health and function 
it is considered ethically ‘right’;125 if a professional model requests the removal of a healthy 
molar so that her facial features are accentuated to give her a better appearance it is regarded 
as ethically ‘wrong.’126 The ethical position in these examples is fairly obvious and most 
practising clinicians would be in agreement.  
In aesthetic dentistry, however, subjectivity can outweigh objectivity.127 Clinicians in their 
daily practice are faced with problems and challenges regarding treatment management. The 
role of a dentist in providing cosmetic procedures or aesthetic treatment is threefold: 
professional, clinical and profit-based. In some situations two or more of these roles may be in 
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conflict with each other.128 In such a case, the dentist must ensure that they honour all four 
principles of ethics in their duty of care. 
2.7. Legal issues surrounding administration of dental Botox 
There are legal implications surrounding the administration of dental Botox which are 
applicable to the wider medical profession: such as medical malpractice cases, a Botox 
procedure gone wrong, issues of negligence which encompass failure to exercise duty of care, 
or failure to obtain informed consent. Such legal implications as delictual claims against 
dentists arising from medical negligence due to failure to exercise the duty of care between the 
dental surgeon and the patient are to be considered.  
Demonstrating cause 
As mentioned previously, medical negligence or culpa must be proved against a dentist who 
administers Botox to a dental patient using the reasonable person test established in Kruger v 
Coetzee129. The reasonable person test requires that the dentist administering Botox ought to 
have foreseen, in his capacity as a dentist (given his training, skills and expertise), that his 
conduct (through an act of commission or omission) would have caused harm or injury to the 
patient. Common law requires a link between the action of the dental surgeon and the harm 
caused to the patient. This link is causation. For medical negligence, as discussed earlier, the 
dentist’s action must be demonstrated to be the cause of the patient’s injury or harm: in the 
case of the administration of Botox, either through incompetence by acting outside of the scope 
of his or her practice; administering a dose beyond the prescribed limit; failing to obtain 
informed consent; or through failure to exercise any other duty of care. Without demonstrating 
causation it is difficult to prove negligence. Equally important is the non-applicability of the 
doctrine of res ipsa loquitur which was rejected by South African courts in Mitchell v Dixon130, 
especially in medical malpractice cases. The argument against this doctrine is that the facts do 
not necessarily speak for themselves: for example, the fact that a patient develops injuries or 
gets worse immediately after a Botox procedure is not prima facie proof that the dentist was 
negligent. The court would determine whether negligence or failure to exercise the duty of care 
were the cause of injury in the case. 
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Performing cosmetic procedures 
The question whether it is ethical for dentists to conduct procedures purely for aesthetic reasons 
is a critical one.131 In practice, medical or dental professionalism is defined as “a combination 
of vocation and enhancing health and function.”132 Cosmetic procedures, however, because 
they do not necessarily have health or functional benefits, lie outside the scope of professional 
practice.133 A client seeking cosmetic therapy from a dentist or medical practitioner must 
understand that the ethical standards that apply to professional medicine or dentistry will not 
apply to the cosmetic procedure. While the client of a professional service provider may bring 
a lawsuit against them for failure to comply with the standards of their profession, for the client 
of a non-professional practitioner such as a hairdresser or tattoo artist personal litigation is the 
only recourse.134 In effect, the patient cannot have it both ways: on the one hand expect 
fiduciary judgment from a professional, and on the other dictate the treatment they want for 
non-health purposes.135 A dental surgeon who administers cosmetic services should also reduce 
his or her rate for these services as he or she is effectively providing them as a ‘skilled trader’ 
rather than as a ‘professional’.136 Both parties must be aware that the patient cannot hold the 
dental surgeon responsible ethically for his or her cosmetic work, and the dental surgeon cannot 
claim professional status while performing a cosmetic service because it is a business, rather 
than a professional transaction.137 
A variety of arguments are made to justify the value of cosmetic dentistry; some of these have 
greater validity than others. Most commonly, the client requesting cosmetic dentistry is seeking 
to whiten or straighten his or her teeth or to close gaps due to missing teeth.  
One argument for cosmetic dentistry is that it aids the ‘psychological healing” of the client. 
This argument lacks validity, however. Firstly, few dental surgeons are psychologists; an 
attempt to dabble in psychology thus involves practising beyond the scope of dentistry.138 
Secondly, while the argument is made that improving a smile can increase self-esteem and 
confidence and benefit social interactions or career opportunities, these possible gains are, in 
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fact, ethereal.139 Dentists are not qualified to assess or address the emotional needs of a client.140 
In addition, a failed cosmetic procedure can negatively impact the very emotional or social 
aspects of the client’s life which they sought to improve.141 Thirdly, studies have demonstrated 
that a number of aesthetic procedures are merely fads and provide a client a passing sense of 
gratification with no lasting value. 142Finally, if a client makes the case that they require the 
procedure for their mental health, it raises the question whether the client is in sound mind to 
give informed consent for the procedure.143 Informed consent is only valid if the person (or 
surrogate) is of sound mind and has been presented with the potential side effects and success 
rates associated with the prospective treatment.144 When a dentist presents images showing 
only the most successful outcomes of the procedure, they are not adequately informing the 
patient.145 
Another argument made for aesthetic dentistry is the ‘golden proportion’ (GP).146  The GP is a 
framework for natural beauty. However, if all plant and animal species complied with the GP 
they would be mere replicas of each other.147 The argument can be made that beauty lies not in 
conformity to the GP, but in diversity.148 Many lecturers, however, have a fondness for the GP 
and thus promote cosmetic dentistry to their students.149 Pursuing the GP as an ideal, however, 
is not in the interests of the dental health of clients – although it may promote monetary gain 
for the practitioner.150 Studies have shown, for example, that the maxillary anterior teeth 
comply with the GP in only 17% of the population.151 If one were to accept the idea that the 
GP represents the single standard of ‘perfect’ beauty, it would follow that the majority of the 
population is imperfect in this regard. If this was the case, damaging the enamel and dentine of 
one’s teeth would be the only way to attain ‘ideal’ beauty. This leads to larger debates around 
whether it is ethical to use genetic engineering to create ‘designer’ human beings.152  
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Recently, there has been a trend to market extensive posterior and anterior restorative work on 
cosmetic grounds. After carrying out a detailed occlusal analysis, the practitioner informs the 
patient of various occlusal problems such as defective contacts, grinding patterns, TMJ and 
clicking. To address these problems, a full mouth rehabilitation is presented as the only 
solution. Most dental surgeons understand occlusion as unexplained, and lecturers of aesthetic 
dentistry manipulate this weakness for advising on veneers and crowns, which is more gain for 
them.153 This faulty logic argues that achieving perfect occlusal relationships will resolve 
occlusal problems. However, why should an imperfect occlusal relationship be addressed if it 
is causing no discomfort to the client?  If patients have defective contacts, grinding patterns, 
wear facets or TMJ clicking without deleterious clinical findings or symptoms, it cannot be 
justified to propose the more destructive course of action of providing veneers or crowns. Many 
patients have occlusal irregularities which cause them no difficulties; however, clinical 
intervention could introduce new issues which the patient had not experienced before.154 
Regardless of the aesthetic goal or proposed procedure, the clinician bears an obligation to 
advise the client of the least invasive and optimal options which are supported by scientific 
research and have acceptable endurance with minimal risk of complications. Pincusone, one of 
the ‘godfathers’ of aesthetic dentistry, advised that: “There is nothing permanent in 
dentistry.”155 If a minimal or least invasive procedure is performed, the chances of success and 
longevity are greatest. More invasive procedures are typically accompanied by greater risk of 
complications.156 As all treatment modalities have advantages and disadvantages a compromise 
is often necessary. It may be best to sacrifice the most optimal aesthetic outcome to achieve 
better function and a longer duration of benefit. It is essential that all possible advantages and 
disadvantages of each alternative procedure are thoroughly discussed with the patient.  
Performing procedures beyond the scope of dentistry 
If a procedure is unrelated to dentistry and beyond the scope of practice, it can be argued that 
a dentist should not perform it, irrespective of the training or certification the dentist has 
obtained. Thus it would be illegal and unethical for a dentist trained or certified to administer 
Botox treatment for procedures that are either beyond the scope of dentistry or unrelated to 
dentistry. There is, however, need to clarify circumstances in which the use of botulinum toxin 
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A and related treatments is linked to the practice and scope of dentistry. The peri-oral area, 
including the lips, cheeks and jaw, falls within the scope of dentistry but parts of the face 
outside these areas do not.157 The HPCSA guidelines dictate that dental Botox may only be 
practiced by a registered specialist who has received training from an examination body 
accredited by the Board.158 
Until 2007, there was disagreement regarding the suitability of Botox in dentistry.159 Ramphora 
notes that dentists who began to administer Botox were sometimes accused of abandoning their 
traditional role of repairing gums and teeth.160 Botox, which had quickly gained popularity, 
was criticised as a money making technique which fell outside the scope of dentistry.161 
Dentists who performed Botox were accused of being materialistic and self-serving, as well as 
showing little concern for the welfare of patients.162 
It is safe to say that the HPCSA accepts that the provision of Botox for non-therapeutic 
cosmetic treatments is within the scope of the practice of dentistry, thus there are no legal 
restrictions prohibiting dentists from administering Botox in South Africa.163 Although the use 
of Botox falls within the scope of legal practice of dentists, it does present some legal issues. 
Opinions regarding the legality of dentists administering Botox to their patients are varied. One 
of the opinions is that if a procedure goes beyond the scope of dental tuition, it cannot be 
undertaken by a dental surgeon, irrespective of the training or certification he or she has 
received.164 Thus it would be illegal and unethical for a trained or certificated dentist to 
administer Botox treatment for procedures that are either beyond the scope of dentistry or are 
unrelated to dentistry.165 There is, however, a need to clarify circumstances when the use of 
botulinum toxin A and similar treatments can be deemed to be related to the dental arena. It 
may be debated that aesthetic dental procedures involving peri-oral regions such as the lips, 
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cheeks or jaw would be associated, but procedures beyond those selected areas would not be 
considered within the scope of dentistry.166 
There is no law in South Africa that expressly restricts dentists from administering Botox. The 
safety and wellbeing of patients must be the principal consideration, and the patient’s right to 
choose their treatment and practitioner is vital to patient autonomy. However, many of these 
procedures may carry risks which are inherent to the procedures, result from the ignorance of 
the clinician or relate to the individual physiology of the patient.167 Some patients may even 
present with a true body dysmorphic disorder (BDD) which a dental practitioner may not have 
the training or experience to recognise.168 In addition, the expectations of patients of the 
outcome may be unrealistic. Thus it is vital that the consent process be carried out in all 
cosmetic procedures.169 
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CHAPTER THREE: EXPLORING LEGAL ISSUES WHICH HAVE ARISEN IN THE 
USE OF BOTOX BY DENTISTS IN THE UNITED KINGDOM AND THE 
UNITED STATES OF AMERICA 
3.1. Introduction  
This chapter focuses on the way in which the United Kingdom (UK) and the United States of 
America (USA) have identified and addressed legal issues arising from the use of dental Botox. 
This chapter also explores methods for increasing the competency of dentists in the 
administration of Botox.  
3.2. Administration of Botox by dentists practising in the United Kingdom (UK) 
This section examines the management of dental Botox by the UK, including the principles of 
care established by the General Dental Council, the training of dentists and the overseeing of 
their competency. 
3.2.1 Governance of dentistry in the UK  
Dental practice in the UK is regulated by the General Dental Council (GDC),1 a regulatory 
body which is the counterpart of the HPCSA in South Africa, albeit with a specific focus on 
dentistry. The GDC was founded in 1956 with the primary objectives of establishing and 
maintaining standards to regulate dentistry in the UK for the protection and benefit of both 
practitioners and patients.2 The GDC maintains a current register of all qualified dental care 
professionals which kept up to date, as the council aims take the lead in UK’s health care 
regulation and seeks to promote and instil general public’s confidence in the dental profession.3 
The GDC facilitates practitioners’ maintenance of current knowledge and skills, controls the 
quality of dental education in the UK that patients receive from dental professionals and 
provides assistance to patients in terms of answering questions or attending to their 
complaints.4 The Council liaises between government, practitioners and the public.5  
In the UK, legal challenges related to dentistry typically arise from complaints (usually against 
an individual practice but also, on occasion, against the Dental Complaints Service itself); 
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claims for compensation (with or without the involvement of solicitors and/or issuance of legal 
proceedings); the involvement of the General Dental Council (GDC) or other agencies; or a 
combination of these processes and redress mechanisms for victims.6 
In 2008, the GDC announced that the administration of Botox and dermal fillers away from the 
perioral or immediate perioral area does not fall within the practice of dentistry.7 This means 
that any practitioner found to have performed a non-cosmetic procedure using Botox outside 
the perioral area is liable for prosecution. The GDC states that ‘unconventional or 
complementary’ therapies which are not provided in combination with, or related to, a patient’s 
dental treatment must be conducted separately from the practice of dentistry.8 
3.2.2 Principles of care prescribed by the GDC  
The principles of care outlined by the GDC cover the following areas: prioritising patients’ 
interests; communicating effectively with patients; securing valid patient consent; maintaining 
and protecting patients’ information; establishing an effective complaints procedure; ensuring 
that the clinical environment supports patients’ best interests; ensuring that dental professionals 
uphold, progress, improve  and work according to their  professional expert knowledge and 
proficiencies;  highlighting and addressing concerns around risk to patients; and ensuring 
patients’ confidence in practitioners and in the dental profession.9 
3.2.3 GDC guidelines and dental Botox  
Dental practitioners who wish to offer Botox or other non-surgical cosmetic procedures outside 
their scope of practice should be cognisant of the fact that the GDC requires that they maintain 
a high standard of care irrespective of the type of treatment they offer patients. Practitioners 
are required to restrict the services they offer to their areas of expertise to ensure that they have 
the necessary competence to exercise good judgement. Dental practitioners are required to 
maintain a professional standard when promoting Botox services and ensure that indemnity 
accompanies Botox procedures. The GDC’s Guidance on Direct Access states that: 
The administration of Botox is not the practice of dentistry and so it does not 
appear in the GDC’s Scope of Practice document. However Botox is a 
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prescription-only medicine (POM) and needs to be prescribed by a registered 
doctor or dentist who has completed a full assessment of the patient.10  
 
3.2.4 The British Dental Association (BDA) 
The British Dental Association (BDA) is a professional association and a registered trade union 
which represents dentists in the United Kingdom. Its mission is to “encourage the interests of 
members, enhance and develop the realm of dentistry with the ultimate aim of improving the 
nation’s oral health.”11 The organisation represents practitioners at the national and local levels. 
The mandate of the BDA is to promote safe, appropriate practice and patient management; it 
provides professional guidance to its members in all matters in order to facilitate ongoing 
professional development.12 The organisation also promotes advanced standards (often in 
collaboration with other institutions) and fosters advances in the oral health of the United 
Kingdom. 
3.2.4.1 The policy of the BDA with regard to the use of Botox in dentistry 
As the GDC does not view the administration of Botox as falling within the scope of dentistry, 
it is not addressed in the dental curriculum at an undergraduate level.13 The BDA is silent on 
whether dentists may administer of Botox and provides no guidance on whether dentists may 
carry out other similar procedures, including preparations that currently do not fall within the 
scope of dentistry.14 The BDA does, however, provide strong recommendations which include 
that dentists performing Botox or other related procedures must have adequate training and 
competency in this area of practice.15 Any practitioner administering Botox must ensure that 
he or she has received training of an adequate standard, secure informed consent from patients 
and ensure that his or her duty of care is adequately met.16 A patient wishing to undergo Botox 
treatment must secure professional indemnity beforehand.17 
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3.2.5 Competency of dentists in the UK  
In the UK, opinions on whether or not registered dentists should be permitted to provide facial 
aesthetic procedures, and the extent to which such procedures should be regulated, range 
widely.18 The use of injectable materials such as collagen by dentists began to increase in the 
late 1980s but has never become widespread.19 The use of Botox in the field of maxilla-facial 
aesthetics has gained momentum in the last two decades with the small but increasing number 
of dentists who have ventured into the field of facial aesthetics using injectable dermal fillers 
and Botox.20 In some cases, these procedures are being undertaken for the purpose of changing 
a patient’s appearance only. In other instances, they are being used as a secondary procedure 
to support other dental procedures of a non-aesthetic nature. An example is treatment involving 
dermal fillers or botulinum toxin which is carried out alongside the provision of conventional 
dentures for purposes of improving the overall aesthetic appearance of the patient.21 
3.2.6 Qualifications and training for the administration of Botox  
The Constitution of the National Health Service (NHS) of England provides regulating 
principles and outlines the rights and responsibilities of various role players in health care.22 In 
2013-2015, Health Education England (HEE), with the authorisation of the Department of 
Health, worked with industry and professional experts to “review the credentials required for 
non-invasive cosmetic procedures and the professional qualifications required to be appropriate 
prescribers, and generate recommendations on the accreditation of qualifications and 
curriculum provision.”23   
The Keogh Review, which describes the outcome of the first phase of this programme, noted 
that currently there are no criteria for who may conduct non-cosmetic procedures and no 
accredited training programme exists and points out that as a patient’s decision to undergo a 
cosmetic procedure can impact their health and wellbeing, it is important that they select a 
practitioner who has adequate training and expertise.24 The report recommends that 
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requirements for training be developed by various professional groups and portions of the 
curriculum which have been covered prior to the training and those courses which are to follow 
should be identified in order to complete the training.25 This means that these professional 
groups would not go into the training at the same time and, further, that professional training 
may be provided to practitioners with no previous experience. The report also recommends that 
each practitioner wishing to offer this range of medical procedures acquire the necessary skills 
and expertise to do so in a manner that is safe and meets professional standards.26 The report 
further recommends that the curriculum and training requirements must be subjected to regular 
reviews to guarantee that all practitioners are acceptably trained in new techniques.27 
Stemming from the Keogh Review, a wide range of dental courses are offered at present in the 
UK. For the administration of Botox, the Foundation Botox Dermal Filler training course or 
the Level 7 Certificate in Botox and Dermal Fillers is recommended, and this recommendation 
is confirmed by the recommendations contained in the NHS report published in 2014.28 
Foundation Botox and Dermal Filler is a one day introductory course designed to provide the 
dentist with foundational skills in both the Botox and dermal filler techniques and provides a 
certificate of attendance which is recognised by all major insurance companies.29 The Level 7 
Certificate in Botox and Dermal Fillers is a comprehensive 277 hour accredited training course 
in medical aesthetic techniques which includes practical group work and one-on-one 
workshops, online training and objectively structured clinical examinations (OSCEs) which all 
culminate into a recognised qualification.30 All courses are continuous progressive 
development (CPD) certified and enable the dentist to obtain indemnity to start practising 
immediately. Continuous support is also offered after completion of course work as part of this 
course package.31 
3.3. Governance of dentistry in the United States of America (USA) 
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Legal issues surrounding Botox are derived from the code of conduct governing all dental 
practitioners in the USA. 32 
Dentists in the USA, irrespective of their area of specialisation, are guilty of committing an 
offense if they are found to have administered Botox without first obtaining informed consent 
from their patients.33  A general guideline as to what constitutes informed consent is provided 
by the American Dental Association.34 Statements that should be excluded include those that 
contain a material misrepresentation of fact; exclude a fact necessary to declare the whole 
statement not materially false; are planned or are expected to construct an untenable  
expectancy about outcomes that a dentist is able to accomplish; and those that contain a 
material, unbiased representation, whether communicated or inferred, that “the marketed  
services are of higher quality to those of other dentists, if that representation is not subject to 
acceptable  authentication.”35  
In the USA, biased statements regarding the quality of dental services can also constitute an 
ethical issue.36 Statements of personal views may be considered to constitute misinformation 
if they are not objectively grounded, if they misrepresent the qualifications of the professional 
or the basis of the opinion, or if the patient reasonably interprets them as implied statements of 
fact.37 Claims against such statements are assessed case by case with consideration for how a 
patient might reasonably be expected to be affected or to react to the advertisement in its 
entirety.38 
 
While dental practice in the US is regulated on a state-by-state basis, across the board 
candidates for a dental license must first meet three prerequisites: complete an accredited 
training programme; pass a formal written examination; and pass a clinical examination.39 In 
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each state, a dental practice act establishes boards comprised of practitioners and clients.40 
These boards are responsible for licensing, regulating and disciplining medical professionals 
in accordance with their scope of practice.41 The state’s practice act mandates that only licensed 
practitioners may perform the procedures or services specified for a particular profession. This 
serves to protect the profession from incompetency and unethical, illegal or deceitful practices. 
Although statutory law differs in each state, the dental practice acts of various states restrict 
the dentist to procedures in the oral cavity which include the teeth, gums and jaws.42 
In thirteen states, the Dental Practice Act prohibits the practice of specialist dentistry by 
medical practitioners without a dental license.43 The fact that medical practice acts include oral 
health management and treatment indicates that medical practitioners are allowed to provide 
services that previously fell within the purview of a dentist’s scope of practice as long as it is 
authorised by the state dental practice act.44 Certain dental practice laws permit dental 
practitioners to extract teeth, with the exception of one state which prohibits dentists from 
creating or restoring lost or missing teeth.45 Since 2005, Maine has permitted primary care 
doctors to obtain training to undertake dental extractions and perform other basic dental 
procedures due to a shortage of dentists in the state.  The School of Medicine at the University 
of New Mexico also provides a one year placement program for dentists and medical residents 
and doctors are permitted to undertake studies in fundamental dentistry.46  
Scope of practice curtails the growth of dentistry in the US as dental practitioners who perform 
procedures outside of the defined scope of their practice risk criminal action and face financial 
penalties. In the event that a licensing board learns that an individual is performing services 
outside the scope of the practice for which he or she is licenced, it can launch investigations 
and level charges against the individual for unauthorised practice where necessary. As a result, 
medical practitioners are most often cautious to undertake any procedures in accordance with 
their scope of practice and they exercise caution in expanding their scope of practice, unless 
such expansion of the scope of practice has been previously determined and sanctioned.47 
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While medical and dental practice acts define the scope of practice of each profession, there 
are areas, such as medical emergencies and patient screening, where the practice acts are 
ambiguous.48 
US law mandates that the prescription of botulinum toxin for therapeutic purposes may only 
be done by a qualified practitioner. Attaining this level of qualification requires a substantial 
amount of study time.49 However, Botox may only be administered by a qualified dental 
practitioner. Non-prescribing nurses may not administer dental Botox even if a qualified 
dental practitioner is present. Delegating the administration of Botox by a dental 
practitioner to a less qualified dental assistant is illegal in the USA and is deemed unsafe 
for the patient.50 This corresponds with the position of the HPCSA in South Africa 
discussed in Chapter 1, as well as the ruling in the case of South African Dental Association 
v Minister of Health 51 that it is illegal for dentists to delegate their duties to dental assistants, 
especially in instances where skills and medicine are involved. 
The American Dental Association (ADA) does not specifically deal with facial cosmetic 
surgery or treatment, however it defines the scope of dentistry as being limited to the “human 
teeth, oral cavity, alveolar process, gums, jaws, or directly related and adjacent masticatory 
structures”.52  Dentists who possess an ADA specialisation for oral and maxillofacial surgery, 
however, are authorised to engage in a greater scope of work. This incorporates the diagnosis, 
surgical and secondary treatment of diseases, injuries and flaws, including the “functional and 
the cosmetic features of both the hard and soft tissues of the oral and maxillofacial areas”.53 
The ADA Board declares that the use of facial aesthetic methods external to the stomatognathic 
system is outside the scope of practice for a dentist without a specialisation in oral and 
maxillofacial surgery. The stomatognathic system is an anatomic system which involves the 
teeth, jaws and related soft tissues; its functions include speech, mastication and deglutition.54 
Any dentist in the USA who administers Botox outside of this system is therefore guilty of a 
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criminal offence and may face prosecution.55 The use of Botox for separate aesthetic reasons 
is specifically allowed for dentists who hold a specialisation in oral and maxillofacial surgery.56 
3.3.1 Selected state laws governing dental botox 
In the USA, laws governing the use of Botox and dermal fillers vary from state to state.57 In 
most states, a dental board regulates general dentistry and provides specific guidance on the 
administration of dental Botox.58 Medical practitioners including plastic surgeons, nurses, 
internal medicine physicians, ophthalmologists, dermatologists, podiatrists, dentists, 
obstetricians, medical aestheticians, and physician’s assistants may issue Botox as per the 
provisions of each state’s laws. Although the pioneer of Botox usage in all facial treatment, Dr. 
Howard Katz, is a professional dental practitioner, outdated regulations that do not allow 
dentists to administer Botox are still applicable certain states.59  
In the states of Mississippi and Virginia, the use of Botox in dentistry is restricted to oral and 
maxillofacial surgeons who possess the required professional qualifications.60 
In Arkansas and Louisiana, use of Botox by dentists requires that a dentist complete a course 
offered by an accredited program of the American Dental Association and/or the dental board 
of the state.61 These two states further require that such a training course should cover such 
topics as patient consultation and patient assessment; uses and contraindications of Botox; 
potential risks and side effects associated with Botox and related treatments and how to manage 
them; preparation and administration of the injections; therapeutic uses of the drugs; and hands-
on training with actual patients.62 Dentists are required to administer Botox exclusively in their 
dental offices and are prohibited from allowing support staff, such as dental nurses and 
hygienists, to administer Botox on their behalf.63 
The states of Massachusetts, New Mexico, Pennsylvania, South Carolina, South Dakota, and 
Wyoming do not currently regulate the use of Botox by dentists. However, many malpractice 
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57 H. Katz’ (2014)  State by State by State Dental Botox Laws in the US,’ available on  http://dentox.com/state-









insurance carriers still require that anyone administering Botox or dermal fillers complete an 
appropriate training course.64 Some of these states are beginning the process of putting 
regulations in place.65 
The Board of Dentistry and Dental Hygiene in Delaware refuses to take a position on whether 
dentists may administer Botox.  Delaware considers possible violations regarding dentists 
administering Botox on the merits of each case.66 
Dentists in Alaska are permitted to perform any cosmetic procedure on the condition that the 
procedure is part of a patient’s dental treatment plan.67 
The dental board in Connecticut allows dentists to undertake Botox procedures only insofar as 
such procedures relate to the mouth and its structures, including the jaw.68 This is similar to 
Texas, where the Dental Board does not specifically regulate cosmetic procedures but confines 
the scope of dentistry to procedures that involve the teeth, mouth, gums, jaws and related 
structures.69 
In Idaho, the Board notes that the dental practice law is broad enough in scope to allow dentists 
to administer Botox and dermal fillers.70 The Board also mandates that practitioners bear a 
responsibility to obtain adequate training to ensure their competence for any procedure they 
perform.71 
In Iowa, the law limits dentists to the provision of treatments as specified by the scope of 
practice of dentistry.  For example, dentists are permitted to examine, diagnose and treat 
patients suffering from ailments or deformities and defects in and around the mouth, which 
include the teeth, gums, jaws and associated structures and tissue.72 Appropriate treatments 
may be carried out for such ailments and deformities, including the administration of 
medications, appliances or surgery; however the methods must relate to the practice of dentistry 
and the dental practitioner is required to be in possession of adequate training and expertise for 







70 Idaho State Board of Dentistry , available on https://isbd.idaho.gov/IBODPortal/Home.aspx, accessed on 20 
November 2018. 
71 Ibid. 
72 H. Katz’ (2014)  State by State by State Dental Botox Laws in the US,’ available on  http://dentox.com/state-
by-state-dental-botox-regulations/, accessed on 20 November 2018. 
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the methods used.73  A dental examination must be undertaken and the medical history of the 
patient must be obtained before prescribing or administering any medication to the patient.  
With reference to these laws, the Board’s stance is that dentists may use Botox and dermal 
fillers only if such use has a direct bearing and relevance to the dental practice and provided 
that the practitioner has acquired relevant and suitable training in this field of practice.74 These 
laws allow only those dentists who have completed the required program accredited by the 
American Dental Association, which includes the administration of Botox and the use of 
dermal fillers in the curriculum, to undertake Botox procedures.75 This provision is similar to 
the laws passed by the dental board of Louisiana wherein licenses are not necessarily granted 
for Botox usage or dermal fillers but the dental board clearly defines specific obligations. For 
instance, before using Botox or dermal fillers, the dentist ought to have successfully undergone 
training issued by an accredited institution recognized by the Commission on Dental 
Accreditation of the American Dental Association or a continuing education course addressing 
the relevant topics. This requirement for training also extends to the state of Maryland where 
dentists can authorise medicines  for treatments that are  within their  scope of practice and 
must also obtain adequate training in the administration of Botox  and other medications in 
accordance with the Code of Maryland Regulations (COMAR).76  
The same provisions are applicable in New Hampshire, where dentists may conduct procedures 
which are within the scope of practice as defined by NH RSA 317-A:20 on condition that  they 
possess the necessary skills and expertise  to perform such procedures.77 
In Kansas, the dental board has prohibited dentists from the administration of injections which 
are expected to diminish signs of aging and has argued that such procedures are inappropriate 
to the practice of dentistry. To this end, dentists who administer injections for purposes other 
than dental purposes can be subjected to disciplinary action.78  
The Michigan Board of Dentistry issued a statement on Botox in 2012 allowing the use of 
Botox, derma fillers and neurotoxins by dentists on the proviso that they have been properly 






78Dental Boards Organization (2012).Dentists’ Botox Use Laws, available on ,  
from https://www.dentalboards.org/PDFS/2012BackgroundBotox.pdf, accessed on 19 November 2018. 
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trained in this area of practice and on provision that such use is within the dentist’s scope of 
work (defined by MCL 333.1101).79 The Board observed that such use, when administered by 
dentists who are not properly trained or those who practice outside the scope of dental practice, 
puts patients’ lives at risk. The Board further noted that the scope of dental practice applicable 
to general dentists excludes administration of injections of these constituents for aesthetic 
reasons.80 The Board’s position does not constitute a statute or administrative code rule, 
however: it is not binding and therefore cannot be enforced.81 In civil cases where it has to be 
determined whether the use of Botox, derma fillers and neurotoxins falls within a general 
dentist’s scope of work, the statement made by the Board may be submitted and admitted as 
evidence, however the court is under no obligation to support the position of the statement.82 
The Board’s Botox statement can, however, serve as a warning to dentists who routinely use 
these substances without proper training or outside of their scope of practice.  
In Arkansas and Louisiana, the dental boards require dentists wishing to administer Botox to 
obtain training from an institution accredited by the Commission on Dental Accreditation of 
the American Dental Association. The course content must include, “directives on patient 
consultation and assessment when using Botox and dermal fillers, positive effects and 
contraindications for dental Botox, safety and risks involved, the technique on the use of dermal 
fillers to enhance and complete cosmetic dental treatment, how to use Botox to treat disorders 
of the temporomandibular joint and teeth grinding and to identify and control harmful reactions 
and treatment of possible complications.”83 These two states also allow the administration of 
Botox and dermal fillers only at dental practices that observe universally acceptable 
precautions as outlined by the Federal Centers for Disease Control.84 
3.3.2 Training and certification of dentists for the use of Botox  
The American Academy of Facial Aesthetics (AAFE) is the only available training institution 
offering a non-surgical, minimally invasive facial injectable program for clinicians in various 
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states. Three levels of training are offered which include theory, practice monitoring and 
evaluation.85 
In the US, it is argued that dentists are qualified to administer Botox, provided that they have 
received comprehensive training in head and neck function, have an in-depth  knowledge of 
the pharmacology and are experienced in the administration of Botox.86  Benninger et al87 argue 
that the dental curriculum in the US adequately equips dentists to administer Botox. Students 
receive “an accelerated clinical anatomy course below the head and neck and an 11 to 12 week 
specific course of head and neck anatomy compared to their medical colleagues who receive 
on average 2 to 3 weeks of head and neck anatomy education during their first 4 years of 
prequalification training”.88 Benninger et al highlights that dental students administer between 
3000 and 4000 injections “at multiple sites intra and extra orally” during their four years of 
training in dentistry.89 Benninger et al argue that training in general dentistry provides the 
“fundamental knowledge and clinical skills” required for the administration of Botox.90 
3.4. Conclusion  
It is evident that in the USA there are many states where it is considered completely acceptable 
for general dentists to administer Botox and dermal fillers in the oral and maxillofacial areas 
from chin to top of the forehead. However there are some states that may allow one form of 
treatment and not the other, and there are states where dentists are not allowed to conduct these 
therapies at all. There is no question that there is greater demand for the administration of Botox 
to be accepted nationwide, with more state dental boards allowing these procedures. It is 
appropriate for dentists to use Botox and dermal fillers for dental uses within the scope of 
dentistry as defined by the state practice act.91 
The practise of Botox in dentistry in the United Kingdom is grounded in the safety and welfare 
of patients as the superseding consideration, with the patient's right to choose what treatment 
they wish to receive, when, and from whom, as principal to patient autonomy. However, it is 
                                                 
85 American Academy of Facial Aesthetics available at https://www.facialesthetics.org/courses-events/  accessed 
on 12 July 2019. 






91 ‘ Dentists doing Botox. Its about time!’ , available on  https://www.facialesthetics.org/blog/dentists-botox-
time/, accessed on 3 Sept 2019. 
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imperative to bear in mind that patients may well have different levels of expectation and 
willingness to accept a sub-optimal aesthetic outcome. In all ‘cosmetic’ cases the consent 
process is crucially important, yet it is sometimes encumbered by forthcoming difficulties. 
Nevertheless, the need for Botox is increasing and dentistry, properly regulated and practised, 
can and should be given the control.92 
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CHAPTER 4: SUMMARY OF FINDINGS AND RECOMMENDATIONS 
 
4.1. Introduction  
This paper has lent itself to the wider discussion and debate on whether dental practitioners 
should be allowed to administer Botox. This determination is critical, especially in light of the 
multiple uses of Botox in the modern era as enabled by the current demand for youthfulness 
and treatments to curb ageing, on the one hand, and the technological advances in the field of 
medicine, on the other. 
To combat ageing and treat other cosmetic and dental-related ailments botulinum toxin, also 
known as Botox, is increasingly being used.1 As this study has highlighted, Botox has gained 
wide acceptance for its therapeutic characteristics which have come to overshadow its more 
lethal and life-threatening elements. Small doses of botulinum toxin are considered to be safe.2 
These multiple modern day uses of Botox have widened the scope of its application and 
administration to the field of dentistry where Botox is considered a less-invasive treatment of 
‘muscle-generated’ dental ailments such as temporomandibular disorders (TMD), bruxism and 
clenching, among others.3 As with any other medical treatment and procedure, use of Botox 
also has its side effects, including pain at the site where injection is administered and weakening 
of muscles that are injected with Botox; sometimes flu-like symptoms and nausea may also be 
experienced by patients after a Botox procedure.4 However, the benefits of the use of Botox as 
a therapeutic and dental treatment have been established as outweighing the side effects 
highlighted in this study.  
Of particular importance to this study is the fact that in such jurisdictions as the United States 
of America, dental surgeons receive extensive training which encompasses administration and 
use of Botox as part of their scope of practice and, due to this intensive training, they need 
limited additional training to enhance their skills in this field.5 In light of such developments 
in the USA, this study probes whether in South Africa the scope of practice for dentists 
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currently includes a role for their administration of Botox. In simple terms, the main question 
that this study aims to answer is whether dentists can administer Botox or not in South Africa. 
In South Africa, the field of dentistry, just like any other medical profession, is governed by 
the Health Professions Act.6 The Act also determines the scope of practice for dentists.7 Section 
33 of the Health Professions Act8 specifically provides that dentists can “perform any aesthetic 
or cosmetic procedure on a patient to the oral and peri-oral area”. Questions exist as to whether 
the prescribed scope of practice includes all administration of Botox by dentists. The provisions 
of the Act and the guidelines for the dentists’ scope of practice are unclear as to whether it 
includes the administration of Botox. Furthermore, as it is the case with other medical 
procedures, there are legal implications that are attendant to the administration of Botox, 
notwithstanding whether this is done by a dentist or a cosmetic surgeon. Improper 
administration of Botox can give rise to delictual claims against a dentist. The guidelines of the 
Health Professions Council of South Africa (HPCSA) for good practice in the health care 
profession require, for instance, that a medical practitioner ensure that the medical procedure 
performed is within their scope of practice and, further, that they have appropriate training not 
just to administer, but also to mitigate, this medical procedure’s potential adverse effects.9  
In light of these developments, the study specifically sought to respond to the questions: 
whether the administration of Botox falls within the scope of practice of dentists in South 
Africa; whether it constitutes medical malpractice if a dentist administers Botox to a patient’s 
face outside of their scope of practice; whether there is a regulatory framework regarding the 
administration of Botox by dentists; and, lastly, whether law or policy reform is needed on the 
administration of Botox by dentists. The next section will discuss key findings from this study. 
4.2. Summary of findings 
The key findings of the study will be presented according to the four questions of the research 
study highlighted in the study and the introduction above. 
4.2.1. Does the administration of Botox fall within the scope of practice of dentist 
in South Africa? 
                                                 
6 The Health Professions Act 56 of 1974. 
7  https://www.sada.co.za/scope-of-practice/Health Professions Act 56 of 1974, accessed on 3 March 2018. 
8  The Health Professions Act 56 of 1974. 
9 HPCSA Guidelines. 
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With regards to whether the administration of Botox falls within the scope of dentists’ practice, 
this study points out that registered dentists are identified as ‘appropriate practitioners’ and, in 
terms of Section 58(2) of the Medicines Act, they can “procure, prescribe, dispense or 
administer, prescription-only medicines” as part of their scope of practice in the field of 
dentistry.10 The HPCSA guidelines require that dental Botox be administered by a “specialist 
who has received training from an examination body accredited by the Board”.11 According to 
Addendum 2 of the Medicines Control Council of South Africa, injections are to be 
administered by a doctor or a professional registered with the HPCSA.  
The literature engaged in this study has also highlighted that dentists are in a more advantaged 
position than other medical practitioners when it comes to effectively carrying out treatment 
and procedures on facial areas.12 This is largely due to their undergraduate training in anatomy, 
physiology and pharmacology which specialises in the head and neck area.13 Furthermore, the 
regulations defining the Scope of the Professions of Dentistry under the Health Professions Act 
provide that a practitioner “shall only perform, except in an emergency, a professional act for 
which he or she is adequately qualified and sufficiently experienced”.14  
It is further highlighted in this study that it is a requirement for medical practitioners who use 
substances for aesthetic medical procedures on patients to also have the capacity to manage the 
potential side effects, reactions and complications that may be resultant to administering such 
substances during medical procedures.15 The practitioner therefore bears the burden of proof 
to ensure that they have had adequate education, training and experience in the performance of 
any procedure, including the administration of Botox.16 The HPCSA makes it compulsory for 
all members of the medical profession, in their respective areas of specialisation, to 
continuously update their skills and to attend continuous professional development courses. 
This this applies to dentists who administer Botox.  
                                                 
10 Medicines and Related Substances Act 101 of 1965. 
11 Health Professions Council of South Africa’ available at http://isystems. hpcsa.co.za/iregister/, accessed on 15 
March 2018. 
12 https://www.omicsonline.org/should-dentists-be-allowed-to-administer-botulinum-toxin-2161-
1122.1000135.php?aid=7215, accessed on 24 November 2018. 
13http://www.up.ac.za/en/odontology/article/22379/academic-programmes, accessed on 12 May 2018. 
14 HPCSA Guidelines. 
15 https://www.aestheticdoctors.co.za/content/page/about-us , accessed 5 May 2018. 
16 D Mostafa, ‘A successful management of sever gummy smile using gingivectomy and botulinum toxin 
injection: A case report’ (2018) 42. International Journal of Surgery Case Reports 169-174. 
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The study further highlights that although Botox treatment does not form part of the curriculum 
for undergraduate studies in dentistry. The readiness, qualification and skill of dentists to 
administer Botox can be easily addressed through adequate training and exposure that can be 
undertaken in the post graduate years, rendering a dentist a master in the fields of aesthetic and 
therapeutic Botox treatment, building onto the specialised foundation phase of his studies.17 
The study further deduced that it is medical malpractice for a dentist to delegate or authorise 
someone without the requisite competencies to administer Botox in dentistry.18 In South 
African Dental Association v Minister of Health19 the court ruled that it is illegal for a qualified 
dentist to delegate their duties to dental assistants, especially when specialist skills and 
medicine are involved. This is the same standard used in the USA, where administration of 
Botox can only be done by a qualifying dental practitioner and not by any non-prescribing staff 
member. In the context of the USA, a nurse cannot administer Botox even when this is being 
done in the presence of a dental practitioner.20   
In answering the highlighted question, although not expressly provided, it would seem that 
given the wide application of the scope of practice for dentists as prescribed by South Africa’s 
Minister of Health and various legislative and regulatory measures, registered doctors do act 
within their scope of practice to administer Botox. It also follows that dentists who are not 
registered with the HPCSA cannot administer Botox, as this would amount to performing this 
procedure illegally, which can lead to criminal prosecution.21 
4.2.2. Is it medical malpractice if a dentist administers Botox to a patient’s face 
outside of their scope of practice? 
The study has defined medical malpractice as ‘any act or omission by a physician during 
treatment of a patient that deviates from accepted norms of practice in the medical community 
and causes an injury to the patient’. The study further made a distinction between malpractice 
and negligence, and observed that while malpractice refers to both intentional and negligent 
acts committed by medical practitioners, negligence constitutes malpractice when the medical 
practitioner’s negligent treatment causes undue injury to the patient. The study went to define 
malpractice in dentistry as ‘treatment  which is provided by a dental care professional that is 
found to be below the acceptable standard of care expected from a dentist, that results in serious 
                                                 
17 https://www.up.ac.za/odontology/article/22379/academic-programmes accessed on 12 May 2018. 
18 Ibid. 
19 South African Dental Association v Minister of Health (20556/2014) [2015] ZASCA 163 (24 November 2015)  
20 Footnote 39 supra.  
21 Footnote 5 supra. 
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personal injuries sustained by the patient’.22 In highlighting the requirements for proving a 
delictual claim against a dentist arising from a Botox procedure gone wrong, the study has 
highlighted that a patient must prove the following: that the dentist was licensed and registered 
as required by the Health Professionals Act; that they suffered harm; that the dentist failed to 
exercise the duty to care through mistakes and poor treatment; that the mistake or poor 
treatment caused an injury; and that the injury resulted in damages.23  
The HPCSA highlights medical malpractice as including, inter alia, operational procedure 
without the consent of the patient, incompetence in providing treatment to patients and 
insufficient care to patients.24 As highlighted in answering question 1 above, the HPCSA 
regulations provide that a practitioner can only perform a professional act for which he has 
received adequate qualification and sufficient experience, with an exception of emergency 
situations. The study findings point to the fact that in the event where a dentist administers 
Botox to a patient’s face when they do not possess the requisite training in this area, they act 
outside the scope of their practice. This is in line with the provisions of the HPCSA guidelines 
and the Health Professionals Act.25 This conduct further amounts to malpractice. The onus is 
on the practitioner to ensure that they have adequate education, training and experience in the 
performance of a Botox procedure.26 In instances where a dentist does not possess such 
adequate training or sufficient experience in performing a Botox procedure, the practitioner 
has a duty to communicate and work with appropriately qualified health practitioners in the 
treatment of a patient.  If a dentist fails to meet this standard they could be sued for medical 
malpractice. In other words, a dentist commits medical malpractice for undertaking certain 
tasks for which they lack professional competence. This also extends to a qualified professional 
failing to update themself regarding modern trends in the profession. As was pointed out in 
Chapter 1, the HPCSA makes it mandatory for all members of the medical profession, in their 
respective areas of specialisation, to continuously update their skills and to attend continuous 
professional development courses. 
Furthermore, the study has highlighted medical negligence as a form of medical malpractice, 
which is failure on the part of the medical practitioner to exercise ‘a reasonable amount of skill 
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24 http://www.hpcsa.co.za/conduct, accessed on 20 October 2018. 
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and care’ during the medical procedure being undertaken, which renders them liable for 
delictual claims for damages.27 For delictual claims, the courts will require the aggrieved party 
to prove that the medical practitioner’s conduct fell short of the reasonable standards expected 
from someone in their profession. In establishing the ‘reasonable man’ test, which is the 
yardstick for proving a delictual claim for medical negligence, in Kruger v Coetze28 the courts 
found that it is a case of medical negligence if a diligens paterfamilias in the position of the 
defendant not only would have foreseen the reasonable possibility of their conduct injuring 
another in their person or property and causing them patrimonial loss, but would also have 
taken reasonable steps to guard against such an occurrence, and if the defendant failed to take 
such steps. In deciding what is ‘reasonable’, the court will therefore consider the level of skill 
and diligence possessed and exercised at the time by the members of the branch of the 
profession to which the practitioner (in this case, a dentist) belongs.  
With regard to the duty of care, the study has established that in the field of dentistry dental 
practitioners administering Botox to their patients have a duty to take the welfare of their 
patients into consideration.  As with any other medical practitioner, dentists too have a duty to 
exercise extreme caution in administering medicines or drugs that have adverse effects to their 
patients. The study further has established negligence as a form of medical malpractice  in three 
instances: namely, when the dentist acts outside the scope of his or her practice by 
administering Botox; when the dentist is incompetent in administering Botox in dentistry (that 
is when he or she administers Botox without having received the necessary training from an 
examination body accredited by the Board); and when a dentist administers excess dosage of 
Botox above the prescribed limits (which constitutes an offence). 
In conclusion, the study has clearly highlighted that it is, in fact, medical malpractice when a 
dentist administers Botox outside the scope of his practice, whether intentionally or 
negligently, unless this procedure is conducted in an emergency situation.  
4.2.3. Is there a regulatory framework regarding the administration of Botox by 
dentists?  
This study found that the health profession within which dentists practice is regulated. The 
Health Professions Act29 provides for the establishment of the Health Professions Council of 
                                                 
27 P Casterns & D Pearmain ‘Foundational Principles of South African Medical Law’ (2007). Durban. Lexis 
Nexis. 
28 Footnote 41 supra.  
29 The Health Professions Act 56 of 1974. 
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South Africa (HPCSA), the statutory regulatory body responsible for, inter alia, controlling 
and exercising “authority in respect of all matters affecting the training of persons in, and the 
manner of the exercise of the practices pursued in connection with, the diagnosis, treatment or 
prevention of physical or mental defects, illnesses or deficiencies in humankind.” In terms of 
the Act, no person may practise within the Republic of South Africa as a medical practitioner 
unless he or she is registered in terms of the Act.30  
The Act also provides for control over the education, training, registration, and practices of a 
variety of health professionals.31 Furthermore, the Health Professions Act prohibits any person 
from practising within any health profession outside the scope which has been defined by the 
Minister, unless they are registered in terms of the Act in respect of such profession, and 
contravention of this provision amounts to an offence.32 Such offence of acting outside the 
scope defined for such a profession within the medical or health professional field is punishable 
by means of a fine or imprisonment for a period not exceeding twelve months, or both a fine 
and such imprisonment.33  
The study has established that the Medical and Dental Professional Board (MDPB) is 
responsible for all registered medical and dental practitioners, including their training and that 
of medical and dental students. The MDPB falls under the control of the HPCSA, although it 
functions somewhat independently.  
The dental administration of Botox is, therefore, regulated, by virtue of the provisions of the 
Health Professions Act, the regulations, the HPCSA guidelines and the Medicines Control Act. 
However, the provisions of the legislative framework are not explicit and the determination of 
the scope of practice of dentists, in particular, is construed to be wide enough to extend to the 
administration of Botox by dentists. The arguments made in question 1 and 2 infer the existence 
of this regulatory framework.   
4.2.4. Is law or policy reform needed on the administration of Botox by dentists?  
As highlighted in the study, botulinum toxin is a lethal poison with life-threatening 
consequences when not administered properly. Within the context of Botox administration 
procedures, the study has gone to considerable lengths to highlight, on the one hand, the uses 
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31 Section 3 of  the Health Professions Act 56 of 1974. 
32 Section 34(2) of  the Health Professions Act 56 of 1974. 
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and benefits of Botox both in therapeutic, dental and aesthetic treatment procedures and, on the 
other hand, the importance of administering proper dosages of Botox, especially given its 
poisonous characteristics.  
Botox has certainly been demonstrated to have significant value in the dentistry field, 
especially as a less invasive treatment for dental problems. As has been earlier stated, there is 
currently no legislation governing medical malpractice cases, including cases where a Botox 
procedure as a non-invasive dental treatment goes wrong. While common law, through 
delictual claims, has provided recourse for victims of medical negligence and medical 
malpractice, these cases are on the rise. The medical field is well-regulated and the scope of 
any field within the medical practice is provided for by the Minister, as this study found. 
Although this study has established that dentists have the expertise, through their training, to 
administer Botox, and the benefits of Botox as a non-invasive measure for dental procedure, it 
revealed the uncertainty that persists in practice specifically in terms of the scope of practice 
of dentists in administering Botox. Firstly, there is no express provision giving dentists a green 
light in performing Botox procedures. Secondly, the provisions for dentists’ scope of practice 
have not been clearly articulated to include administration of Botox. Dentists’ suitability and 
competence is therefore deduced from a wider application of the existing legislation and 
regulations promulgated by the Minister.  
In light of the lack of specific and explicit policy or legislative provisions on whether dentists 
can administer Botox, this study therefore recommends a policy that will regulate Botox 
procedures, with a specific focus on various practitioners who have undertaken training in areas 
of their medical field that are adequate for administering Botox. Dentists in South Africa would 
fall under this category of trained medical practitioners with adequate training to administer 
Botox. This policy could also outline the various uses of Botox, which go beyond the cosmetic 
or aesthetic purposes. The policy could go further to mandate that dentists undertake continued 
learning courses periodically, to upskill themselves and familiarise themselves with new 
innovations and new developments in the field. The policy could also provide express 
provisions for the scope of practice, the training and skills required and the certification needed 
for dentists to administer Botox for dental-related purposes. 
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The study therefore proposes a legal or policy reform regarding the administration of Botox by 
dentists. This policy could borrow heavily from the practice in the United States of America, 
as highlighted in Chapter 3 above, of incorporating  
4.3. Recommendations 
In light of the findings of the study, it is recommended that South Africa, through its regulatory 
body of medical practitioners, the HPCSA, apply itself to clarifying its position on whether 
dentists can administer Botox under the scope of their practice. Comparative analysis in 
Chapter 3 has clarified the position in the UK, where the Medicines Act regards dentists as 
‘appropriate practitioners’ when it comes to procuring, prescribing and administering Botox.34 
In the United States of America, the Medicines and Healthcare Regulatory Agency (MHRA) 
regulates the use of Botox. There is therefore a strong precedent for the HPCSA to address the 
administration of Botox within the dental practitioners’ scope in the South African framework 
and regulatory landscape. This study therefore recommends that the HPCSA uses its current 
regulatory mandate which is already wide and flexible enough, to promulgate regulations or 
guidelines that focus specifically on the following: 
a. The scope of practice, and its attendant parameters for dentists to administer Botox. 
b. The extended curriculum, provided through under-graduate, post-graduate or further 
professional development courses that is necessary to ensure that dentists are 
adequately trained in the administration of Botox to patients. 
c. The continued review of the curriculum on the administration of Botox to ensure that 
dentists and other practitioners whose scope of practice covers the administration of 
Botox are constantly updated with regard to new procedures and new innovations in 
this field. 
The study has already established that dentists’ practice puts them at an advantaged position 
when it comes to providing treatment and in administering injections to the human face. It 
therefore follows that dentists should be recognised explicitly, through guidelines or policy 
considerations, as medical practitioners who can administer Botox in terms of the South 
African medical standards as set out by the HPCSA. 
                                                 
34 Section 58(2) of the UK Medicines Act, see in K Lewis, ‘Dento legal aspects of non-surgical facial aesthetic 
procedure (2014) 5(2) 39 68. 
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As this study has detailed comprehensively, the HPCSA also regulates education and training 
in the health professions, including the continuing professional development of medical 
practitioners to foster compliance with healthcare standards. Taking the cue from the UK and 
USA cases, this study further recommends the need for the HPCSA to police a high standard 
of care and safety in the administration of Botox by allowing privileges to dentists specifically 
to administer Botox through making it compulsory for dentists to undertake regular continuing 
dental/medical education courses during the course of their practice. This would facilitate safe 
dental treatment to patients using Botox, and would ensure that dentists continuously update 
their basic science knowledge and clinical skill levels, especially in terms of the administration 
of Botox. This would further lead to a decrease in medical malpractice cases against medical 
practitioners, and the number of medical malpractice cases arising from negligence in the 
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